Category: ISO 14791

ISO 13485 Documentation Requirements (2026)

Every document and record ISO 13485 requires — with clause references, document control requirements under Section 4.2, record retention rules, how QMSR changed the documentation landscape, and the seven gaps auditors find most consistently. Built as a reference document quality managers can use before their next audit.

Every document your QMS must have, what auditors check first, and why the gaps between your procedures and your records are where most findings live.

Last Updated: May 2026

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The Binder on the Shelf Is Not a QMS

Years ago, working in a nuclear component facility, I watched a certification audit go sideways in the first thirty minutes. The quality manager had spent six months building what looked like a complete quality management system — binders, procedures, forms, the works. The auditor asked to see the document register. The quality manager pointed to the binder. The auditor asked how documents were controlled at the point of use. The quality manager pointed to the binder again.

The binder was the system. It sat on a shelf in the quality office. The machinists on the floor had printed copies of procedures from three years prior. Nobody had a current revision of anything. The audit did not go well.

ISO 13485 documentation is not about having paperwork. It is about having the right documents, in the right format, accessible to the right people, at the right time — and being able to prove all of that during an audit. The standard is specific about what must be documented, what must be retained as records, and what that documentation must demonstrate.

Under QMSR, which took effect February 2, 2026, FDA now evaluates ISO 13485 documentation requirements against the framework directly. Organizations that treat documentation as a filing exercise rather than a quality system function are finding that gap at inspection.

This article covers every documentation requirement ISO 13485 imposes, where auditors look first, and what a compliant documentation system actually looks like in practice.

In This Guide

  • The difference between documents and records under ISO 13485 — and why it matters for audits
  • Every mandatory document the standard requires
  • Every mandatory record the standard requires
  • Document control requirements under Section 4.2
  • Record retention rules under Section 4.2.5
  • The most common documentation gaps auditors find
  • How QMSR changed the documentation landscape for U.S. medical device manufacturers
  • Decision-stage guidance for organizations at different points in their documentation journey

Start Here (Top Resources)

🔖 Get ISO 13485:2016 → ANSI Webstore — ANSI is the official U.S. distributor of ISO standards, ensuring you receive the controlled, compliant version required for certification audits. Use coupon CC2026 for 5% off.

🔖 Build compliant QMS documentation → 9001Simplified — 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

🔖 Train your team on ISO 13485 documentation requirements → BSI Group — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

🔖 Pursue or maintain ISO 13485 certification → ISOQAR — ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

Browse the What Is ISO 13485? pillar article for full clause context, or use the ISO 13485 Gap Assessment Checklist to identify your specific documentation gaps before your next audit.

Documents vs. Records: The Distinction That Drives Compliance

ISO 13485 treats documents and records as separate categories with different requirements. Confusing them is one of the most consistent sources of documentation findings in surveillance audits.

Documents are instructions, procedures, specifications, and plans — the things that tell people what to do. They are living documents: they can be revised, updated, and superseded. Section 4.2.4 governs their control.

Records are evidence that something was done — completed forms, test results, inspection reports, calibration data, training sign-offs. They are fixed in time: once a record is created, it cannot be altered without creating a documented amendment. Section 4.2.5 governs their control.

The practical distinction matters for two reasons. First, the control requirements differ. Documents need revision control, approval, distribution, and obsolescence management. Records need legibility, identification, storage protection, retrieval, and defined retention periods. A documentation system that applies the same controls to both will have gaps in one or the other.

Second, auditors evaluate them separately. When an auditor asks for a procedure, they are asking for a document. When they ask for evidence, they are asking for a record. Handing an auditor a completed form when they asked for a procedure — or a procedure when they asked for evidence — signals a documentation system that does not understand its own structure.

At this point, most quality managers building or auditing a documentation system should: → Map your document inventory against your record inventory separately. If your document register includes completed forms alongside controlled procedures, your system architecture has a structural problem. 9001Simplified’s documentation kits include pre-structured document and record registers built for ISO 13485 compliance. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

Mandatory Documents Under ISO 13485

ISO 13485 requires specific documented procedures and plans across multiple clauses. These are not optional — certification bodies audit for their existence and their content.

ISO 13485 documentation infographic illustrating mandatory quality management system documents with interconnected process icons for quality manuals, risk management, design planning, procedures, records retention, purchasing controls, and document control requirements.
Certification bodies expect documented procedures, controlled records, and defined plans that demonstrate the quality system operates consistently and remains audit ready — see the full list in the table below.
DocumentClauseWhat It Must Cover
Quality Manual4.2.2Scope of the QMS, exclusions with justification, documented procedures or references, description of QMS process interactions
Document Control Procedure4.2.4Approval, review, revision control, distribution, obsolescence management, external documents
Records Control Procedure4.2.5Identification, storage, protection, retrieval, retention periods, disposition
Management Review Procedure5.6Inputs, outputs, frequency, documentation requirements
Competence, Training & Awareness Procedure6.2How competence is determined, how training is delivered, how competence is evaluated and recorded
Infrastructure Procedure6.3Maintenance of buildings, equipment, and supporting services affecting product quality
Work Environment Procedure6.4Control of work environment conditions where required for product conformity
Risk Management Procedure7.1Risk management process across the product lifecycle, per ISO 14971
Customer-Related Processes Procedure7.2Requirements determination, review, and customer communication
Design & Development Procedure7.3Planning, inputs, outputs, review, verification, validation, transfer, changes (if design is not excluded)
Purchasing Procedure7.4Supplier evaluation, selection, monitoring, and purchasing information
Production & Service Controls Procedure7.5Control of production and service provision, cleanliness, installation, and servicing
Identification & Traceability Procedure7.5.3Product identification throughout realization and traceability requirements
Customer Property Procedure7.5.4Control and safeguarding of customer-supplied product or data
Preservation Procedure7.5.5Preservation of product during processing and delivery
Monitoring & Measurement Equipment Procedure7.6Calibration, verification, and control of measuring equipment
Feedback Procedure8.2.1Post-market surveillance and feedback collection
Complaint Handling Procedure8.2.2Complaint receipt, investigation, and regulatory reporting decisions
Internal Audit Procedure8.2.4Audit planning, conduct, reporting, and follow-up
Nonconforming Product Procedure8.3Identification, segregation, evaluation, and disposition
CAPA Procedure8.5.2 / 8.5.3Corrective and preventive action process, including root cause analysis and effectiveness verification

⚠️ If your organization excludes design and development under Clause 7.3, that exclusion must be justified in the Quality Manual and documented. Exclusions without documented justification are a consistent finding in initial certification audits.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Mandatory Records Under ISO 13485

Records are the evidence your QMS operated as documented. The standard specifies which records must be maintained — these are the minimum. Your procedures may require additional records.

RecordClauseWhat It Must Demonstrate
Management Review Minutes5.6.3Inputs reviewed, decisions made, actions assigned with owners and timelines
Education, Training, Skills & Experience6.2Competence evaluated, training completed, results recorded
Infrastructure Maintenance6.3Maintenance activities and results for quality-critical equipment
Risk Management Records7.1Risk analysis, risk evaluation, risk control, residual risk assessment, post-production monitoring
Customer Requirements Review7.2.2Requirements determined and confirmed before commitment
Design & Development Records7.3Inputs, outputs, reviews, verifications, validations, transfer, and changes (if not excluded)
Design & Development Changes7.3.9Change description, evaluation, verification, validation, approval
Supplier Evaluation Records7.4.1Evaluation criteria, results, and re-evaluation decisions
Production Process Validation7.5.2Validation protocols, results, equipment qualifications
Traceability Records7.5.3.2Unique device identification and traceability through production
Customer Property Records7.5.4Receipt, condition assessment, and disposition of customer property
Calibration Records7.6Equipment identification, calibration standard, results, next due date
Internal Audit Records8.2.4Audit plans, findings, nonconformances, corrective actions, follow-up
Product Monitoring & Measurement8.2.6Evidence of conformity and identification of release authority
Nonconforming Product Records8.3Nature of nonconformity, disposition decision, concession records if applicable
CAPA Records8.5.2 / 8.5.3Root cause analysis, action taken, effectiveness verification with criteria and evidence

➡️ 9001Simplified Documentation Kits — Pre-built ISO 13485 procedures, forms, and record templates covering every mandatory document and record listed above. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

Document Control: What Section 4.2.4 Actually Requires

Section 4.2.4 sets out seven specific requirements for document control. Each one has a practical implementation implication — and each one is evaluated individually during audits.

1. Documents must be approved before use. Approval must be by authorized personnel. Your document control procedure must define who has approval authority for each document type. A document approved by someone outside that authority — or with no documented approval at all — is a nonconformance.

2. Documents must be reviewed, updated as necessary, and re-approved. Review frequency should be defined in your procedure. Documents that have never been reviewed since initial creation are a finding in surveillance audits — particularly if the regulatory environment or production process has changed.

3. Changes and current revision status must be identified. Every controlled document needs a revision identifier — a number, letter, or date — and your document register needs to reflect current revision status. Auditors check this against what is in use.

4. Relevant versions must be available at points of use. This is the binder-on-the-shelf failure. Current controlled versions must be accessible where work is performed. If people work from printed copies, you need a controlled printing process. If work is performed on a production floor, current procedures must be accessible there — not only in the quality office.

5. Documents must be legible and identifiable. This sounds obvious. It is consistently violated by organizations that allow handwritten annotations, informal updates, or degraded printed copies to remain in service.

6. External documents must be identified and controlled. This includes customer drawings, regulatory guidance documents, referenced standards, and supplier specifications. External documents that affect product quality must be listed in your document control system and their current version verified.

7. Obsolete documents must be prevented from unintended use. Obsolete documents must either be removed from all points of use or clearly marked as obsolete. Finding an active workstation with a superseded procedure is a major nonconformance — regardless of whether anyone was actually using it.

If you are under active FDA inspection pressure → BSI Group ISO 13485 Training covers document control implementation and audit preparation in depth. BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

Record Retention: What Section 4.2.5 Actually Requires

Section 4.2.5 requires that records be retained for a period at least equal to the lifetime of the medical device, but not less than two years from the date of product release by the organization.

That two-year floor is the minimum. In practice, most medical device records should be retained significantly longer:

  • Implantable devices — the device lifetime may span decades. Records need to match.
  • Devices with long service lives — the same logic applies.
  • FDA QMSR requirements — align with ISO 13485 on the two-year minimum but your complaint handling procedure may require longer retention for MDR-related records.
  • Customer contractual requirements — OEM customers increasingly specify record retention periods in their supplier quality agreements. These requirements take precedence where they are more stringent than the standard’s minimum.

Your records control procedure must define retention periods for each record type. A blanket “two years” policy applied to all records — including design history files and risk management records for long-life devices — is not compliant.

ProviderWhat You GetBest For
ANSI WebstoreISO 13485:2016 official standardAny organization needing the controlled, compliant version of the standard
9001SimplifiedQMS documentation kits with record templatesOrganizations building documentation from scratch or rebuilding after a major finding
BSI GroupISO 13485 training coursesTeams implementing documentation systems or preparing for initial certification
ISOQARISO 13485 certificationOrganizations ready to pursue or maintain certification

Most organizations building documentation systems from scratch need all three:

This combination covers the standard, the knowledge, and the implementation infrastructure.

The Most Common Documentation Gaps

ISO 13485 documentation gaps infographic illustrating seven common audit findings, including outdated document registers, incomplete supplier records, weak CAPA evidence, missing procedures, and disconnected risk management records within medical device quality systems.
Documentation failures rarely appear as isolated findings. They create chains of audit problems across CAPA, supplier controls, training, management review, and risk management. The gap is usually discovered long after it was created.

These are the findings that appear most consistently in ISO 13485 surveillance audits and QMSR inspections. Each one points to a specific procedure or record requirement.

The Quality Manual references procedures that don’t exist. A common initial certification shortcut is writing a Quality Manual that references a full set of documented procedures — then discovering during the surveillance audit that several of those procedures were never finalized. The Quality Manual and the document register must be synchronized.

The document register is not current. Document registers that haven’t been updated in months, that show revision numbers inconsistent with what is in use, or that are missing entire document categories are a consistent finding. The register is the first thing many auditors check.

Risk management records stop at design transfer. ISO 14971 requires risk management across the product lifecycle. Design-phase risk files with no post-production updates — no connection to complaint data, service reports, or CAPA findings — are incomplete regardless of how thorough the original analysis was. See ISO 14971 vs ISO 13485 for the full lifecycle requirement.

CAPA records close without effectiveness verification evidence. A CAPA record that reads “action implemented — problem resolved” with no supporting data is not a closed CAPA — it is an open finding waiting to be issued. For the complete breakdown of what effectiveness verification requires, see CAPA Requirements in ISO 13485.

Supplier qualification records are incomplete or outdated. An approved supplier list without corresponding qualification evidence, or qualification records for suppliers whose scope has changed without requalification, are consistently cited findings under Clause 7.4.

Training records prove attendance, not competence. Sign-off sheets showing who attended a training session are not competence records. The record must show what competence was evaluated, by what method, and what the result was. See Common Mistakes in ISO 13485 QMS for the full breakdown of this finding.

Management review minutes record presentations, not decisions. Minutes that describe what was presented in management review without documenting what was decided are a major finding under Section 5.6.3. Every input reviewed must produce a documented output — a decision, an action, or a rationale for no action.

How QMSR Changed the Documentation Landscape

FDA’s Quality Management System Regulation, effective February 2, 2026, aligns U.S. medical device QMS requirements with ISO 13485:2016. For documentation, the practical changes are significant.

The Device Master Record (DMR) structure is now explicitly required. Under QMSR, the DMR — which must include device specifications, production process specifications, quality assurance procedures, packaging and labeling specifications, and installation and maintenance procedures — is a specific documentation requirement that ISO 13485 certification alone does not fully address.

Complaint files under 21 CFR 820.198 remain a separate requirement. ISO 13485 requires a complaint handling procedure. QMSR additionally requires that complaint files contain specific elements — including the decision on whether the complaint required investigation and, if so, the results of that investigation — that go beyond what most ISO 13485 complaint procedures specify.

MDR procedures must be documented separately. Medical Device Reporting obligations are a regulatory requirement that sits outside ISO 13485 but must be addressed in your QMS documentation under QMSR.

⚠️ FDA QMSR compliance date was February 2, 2026. If your documentation system has not been reviewed against the four QMSR-specific bridge requirements since that date, that review is overdue. The ISO 13485 Gap Assessment Checklist covers all four QMSR bridge requirements explicitly alongside the standard ISO 13485 clause requirements.

For the full regulatory alignment picture, see FDA QSR vs ISO 13485.

Infographic explaining the major operational and regulatory changes introduced under the FDA QMSR, including terminology alignment, expanded risk management, inspection changes, and ISO 13485 document control requirements.
The FDA’s QMSR transition introduced major changes beyond terminology — expanding risk management expectations, changing inspection structure, and aligning medical device quality systems directly with ISO 13485.

Why Organizations Delay Getting Documentation Right

“We’ll clean it up before the surveillance audit.”

This is the most common delay rationalization — and it consistently produces the worst outcomes. Documentation gaps that accumulate over 11 months cannot be credibly remediated in the 30 days before a surveillance visit. Auditors can identify recently created records. A CAPA file dated three weeks before the audit for a problem that complaint data shows has existed for eight months is not evidence of a functioning QMS — it is evidence of audit preparation, which auditors treat as a different category of finding.

“Our documentation was good enough for initial certification.”

Initial certification evaluates documentation at a point in time against a system that was built to be audited. Surveillance audits evaluate whether that system has been maintained — which means they look at records created since the last audit, not at procedures written before it. Organizations that passed initial certification and then stopped maintaining their documentation systems often face multiple major nonconformances at the first surveillance visit.

“We don’t have the internal resources to build this properly.”

This objection is real — but the cost of building documentation properly before certification is substantially lower than the cost of remediation after a major nonconformance. A documentation kit from 9001Simplified covers every mandatory document and record template in a ready-to-use format. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch. The internal labor required to customize a pre-built kit is a fraction of what is required to build from scratch — and a fraction of what remediation costs after a finding.

Frequently Asked Questions

What documents are required by ISO 13485?

ISO 13485 requires documented procedures covering quality manual, document control, records control, management review, training and competence, risk management, customer requirements, purchasing, production controls, identification and traceability, calibration, feedback, complaint handling, internal audit, nonconforming product, and CAPA. The full list with clause references is in the Mandatory Documents table above.

What records are required by ISO 13485?

ISO 13485 requires records covering management reviews, training and competence evaluations, risk management activities, design and development (if not excluded), supplier evaluations, calibration, internal audits, product monitoring, nonconforming product dispositions, and CAPA activities. The full list with clause references is in the Mandatory Records table above.

How long must ISO 13485 records be retained?

The standard requires retention for at least the lifetime of the device, with a minimum of two years from product release. For implantable devices and devices with long service lives, the retention period is typically longer and should be defined in your records control procedure. FDA QMSR aligns with this minimum but specific record types — particularly MDR-related records — may require longer retention.

Does ISO 13485 require a Quality Manual?

Yes. Section 4.2.2 requires a Quality Manual that defines the scope of the QMS, documents or references procedures, and describes the interactions between QMS processes. The Quality Manual is one of the first documents an auditor requests.

Can we use electronic records to meet ISO 13485 requirements?

Yes — electronic records are acceptable provided your document control system ensures they are controlled, legible, retrievable, and protected from unauthorized modification. Electronic systems used to manage controlled documents must themselves be validated if they affect product quality.

What is the difference between a controlled document and a record under ISO 13485?

A controlled document is an instruction, procedure, or specification that tells people what to do — it can be revised and must be version-controlled. A record is evidence that something was done — it is fixed in time and must be retained according to your records control procedure. Section 4.2.4 governs controlled documents; Section 4.2.5 governs records. The distinction is fundamental to building a compliant documentation system.

Does design and development documentation apply to all medical device manufacturers?

Only if the manufacturer performs design and development activities. If your organization manufactures to customer specifications and does not perform design activities, you may be eligible to exclude Clause 7.3 — but that exclusion must be documented and justified in your Quality Manual. Contract manufacturers who claim a 7.3 exclusion without justification are consistently cited at initial certification.

How do FDA QMSR documentation requirements differ from ISO 13485?

QMSR aligns with ISO 13485 but adds four specific requirements: the Device Master Record structure, complaint files under 21 CFR 820.198, Medical Device Reporting procedures, and corrections and removals procedures. ISO 13485 certification alone does not cover these four requirements. The ISO 13485 Gap Assessment Checklist addresses all four explicitly.

What is the first thing an auditor looks at for ISO 13485 documentation?

Most auditors start with the document register — to verify that controlled documents are listed, revision levels are current, and the register reflects what is actually in use. From there they move to the Quality Manual to verify scope and procedure references. Gaps in either of those two items typically expand the audit’s scope significantly.

Free Resources

📋 Free Download: Manufacturing Compliance Checklist — ISO 9001, 14001, 45001 & OSHA — 50 items with gap scoring across all systems.

📋 Free Download: Supplier Quality Checklist — ISO 9001 Clause 8.4 — all supplier controls auditors evaluate, 45 items with scoring.

📋 Free Download: ISO 9001 Implementation Roadmap — The exact 5-phase process from gap assessment to Stage 2 audit clearance.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Not Sure What to Do Next?

→ You need the official ISO 13485:2016 standard → ANSI Webstore — Use CC2026 for 5% off. ANSI is the official U.S. distributor of ISO standards.

→ You need to build ISO 13485 documentation from scratch → 9001Simplified Documentation Kits — ready-to-use procedures, forms, and record templates for every mandatory document.

→ You need to train your team on documentation requirements → BSI Group ISO 13485 Training — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses.

→ You are ready to pursue ISO 13485 certification → ISOQAR — UKAS-accredited, one of the most recognized certification bodies in the industry.

→ You need to assess your documentation gaps before your next audit → ISO 13485 Gap Assessment Checklist — free, 64 items.

→ You need to understand how QMSR changed your documentation obligations → FDA QSR vs ISO 13485

→ You need to understand CAPA record requirements in depth → CAPA Requirements in ISO 13485

→ You need to understand the most common documentation audit findings → Common Mistakes in ISO 13485 QMS

→ You need to understand how risk management documentation connects to your QMS → ISO 14971 vs ISO 13485

→ You need to understand the full ISO 13485 clause structure → What Is ISO 13485?

→ You want to buy ISO 13485 → Buy ISO 13485

→ You want to browse all medical device standards → explore standards by compliance area

Still figuring out where to start?

If you are not ready to commit to a documentation build yet — that is normal. Most organizations spend several weeks between identifying gaps and starting remediation.

The best next step: → Download the free ISO 13485 Gap Assessment Checklist — it takes 20 minutes and tells you exactly which documents and records you are missing before you spend anything.

Feature image promoting an ISO 13485 Gap Assessment Checklist for medical device manufacturers, contract manufacturers, and component suppliers preparing for certification and FDA QMSR compliance.
ISO 13485 Gap Assessment Checklist designed to help medical device manufacturers identify compliance gaps, prioritize actions, and prepare for certification and FDA QMSR requirements.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The Binder Is Not the System

Documentation is not ISO 13485’s most technically demanding requirement. But it is the foundation every other requirement rests on. Without controlled documents, procedures cannot be consistently followed. Without records, there is no evidence that procedures were followed at all. Without a document control system that connects what is written to what people actually use, the gap between those two things grows quietly — until an auditor measures it.

The organizations that handle documentation audits well are not the ones with the most sophisticated quality management software or the thickest procedure binders. They are the ones whose documentation reflects how work actually gets done — current, accessible, and connected to the records that prove it.

That alignment takes discipline to build and discipline to maintain. It does not take complexity.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

Subscribe below to stay ahead.

Subscribe

* indicates required

Common Mistakes in ISO 13485 QMS (2026)

Seven ISO 13485 QMS mistakes that consistently produce major nonconformances — document control drift, management review gaps, supplier qualification failures, CAPA records closed without verification, risk management treated as a one-time activity, competence records that prove attendance not ability, and internal audits that never find anything. With clause references and fixes for each.

The audit findings that derail medical device manufacturers — and the fixes that prevent them.

Last Updated: May 2026

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Your QMS Passed Initial Certification. Now the Surveillance Audit Found Three Major Nonconformances.

This scenario plays out more often than most quality managers expect.

Initial certification audits are thorough — but they happen at a fixed point in time, against a QMS that was built specifically to pass them. Surveillance audits arrive 12 months later and evaluate how the system actually operates day to day. That gap between what was built and what runs is where most findings live.

The mistakes in this article are not obscure edge cases. They are the findings that certification bodies issue most consistently, that FDA investigators flag most frequently under QMSR, and that experienced quality practitioners see repeated across organizations of every size. Some of them look like documentation failures. Most of them are process failures wearing documentation’s clothes.

If you are preparing for a first certification audit, a surveillance visit, or an FDA QMSR inspection, this list tells you where to look before the auditor does.

In This Guide

  • The most common mistakes in ISO 13485 QMS by clause
  • Why document control failures are almost never about documents
  • The management review gap that catches organizations by surprise
  • How supplier qualification problems compound over time
  • What auditors find when they look at CAPA records
  • The risk management connection most QMS procedures miss
  • Decision-stage guidance for organizations at different points in their compliance journey

Start Here (Top Resources)

🔖 Get ISO 13485:2016 → ANSI Webstore — ANSI is the official U.S. distributor of ISO standards, ensuring you receive the controlled, compliant version required for certification audits. Use coupon CC2026 for 5% off.

🔖 Build compliant QMS documentation → 9001Simplified — 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

🔖 Train your team on ISO 13485 → BSI Group — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

🔖 Pursue or maintain ISO 13485 certification → ISOQAR — ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

Browse the What Is ISO 13485? pillar article for full clause context, or use the ISO 13485 Gap Assessment Checklist to identify your specific gaps before your next audit.

Mistake 1: Document Control That Controls Nothing

The clause: ISO 13485 Section 4.2 — Document Control

What auditors find: Obsolete procedures still accessible in shared drives. Forms in use that don’t match the current controlled version. Employees working from printed copies with no revision date. Documents approved by someone whose role no longer includes that authority.

Document control failures are the most consistently cited finding in ISO 13485 surveillance audits — not because organizations don’t have document control procedures, but because those procedures don’t match how people actually access and use documents day to day.

The standard requires that documents be reviewed and approved before use, that current versions are available at points of use, and that obsolete documents are prevented from unintended use. Each of those three requirements has failed in organizations that had a document control procedure on file.

The fix: Document control is an access problem, not a paperwork problem. The question is not “do we have a procedure?” — it’s “can an employee working right now reach a document that has been superseded?” If the answer is yes, your document control system is not functioning regardless of what your procedure says.

Audit your access architecture — shared drives, QMS software, printed SOPs at workstations — before an auditor does. Every document a user can reach should be the current controlled version. Everything else should require deliberate action to retrieve.

At this point, most quality managers in this position should: → Pull your document control procedure and map it against actual employee access. If those two things don’t match, 9001Simplified’s documentation kits include document control templates built specifically for ISO 13485 compliance. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

Mistake 2: Management Review Without Documented Outputs

The clause: ISO 13485 Section 5.6 — Management Review

What auditors find: Meeting minutes that record attendance and agenda items but contain no documented decisions. Review inputs listed without evidence they were actually analyzed. Action items described without owners, deadlines, or follow-up records. Reviews conducted annually when the organization’s risk profile warranted more frequent review.

ISO 13485 Section 5.6.3 is explicit: management review outputs must include decisions and actions related to improvement of the QMS, improvement of product to meet customer requirements, and resource needs. A management review that happened but produced no documented decisions is a nonconformance — regardless of what was discussed in the room.

This finding catches organizations off guard because the review itself felt thorough. Leadership reviewed quality objectives, discussed complaint trends, walked through audit results. But the meeting minutes read like a summary of what was presented, not a record of what was decided.

The fix: Management review outputs need to look like decisions, not summaries. For each input reviewed, the record should show: what the data indicated, what conclusion was reached, and what — if anything — will be done about it. “Complaint trend reviewed — no action required” is a decision. “Complaint data presented” is not.

⚠️ Under QMSR, FDA inspectors now evaluate management review as part of every inspection. Inspectors who find management reviews without documented outputs routinely cite this as a systemic QMS failure, not an administrative lapse.

Mistake 3: Supplier Qualification on Paper Only

ISO 13485 supplier qualification infographic illustrating risk-based supplier controls under Clause 7.4, featuring a supplier risk tier matrix, qualification lifecycle process, ongoing monitoring activities, and common supplier management mistakes.
Supplier qualification under ISO 13485 is not a one-time approval exercise. Risk classification, qualification activities, performance monitoring, and periodic re-evaluation must work as a continuous lifecycle.

The clause: ISO 13485 Section 7.4 — Purchasing / Supplier Controls

What auditors find: An approved supplier list that has not been updated in years. Suppliers qualified based on a questionnaire with no follow-up evaluation. Critical suppliers with no documented performance monitoring. Qualification records for suppliers whose scope of supply has expanded beyond what was originally evaluated.

Supplier qualification failures compound over time in a way that most other QMS failures don’t. A supplier that was qualified five years ago may have changed ownership, changed manufacturing processes, changed subcontractors, or expanded into new product categories — none of which triggered a requalification because the procedure didn’t require one.

ISO 13485 requires that purchasing controls be proportionate to the risk the supplier presents to product quality and patient safety. That proportionality has to be reflected in your qualification criteria, your monitoring frequency, and your records. An approved supplier list populated with names and no evaluation data is not a supplier qualification program.

The fix: Supplier qualification is a living process, not a one-time gate. Your procedure should define evaluation criteria by supplier risk tier, monitoring frequency, requalification triggers, and what happens when a supplier fails to meet performance criteria. If you are using the Supplier Quality Checklist, the ISO 13485 Clause 7.4 section identifies every supplier control element auditors evaluate — including the ones most procedures leave undocumented.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Mistake 4: CAPA Records That Close Without Verification

ISO 13485 CAPA infographic comparing incorrect and correct closure methods, showing the difference between closing corrective actions without effectiveness verification and closing them with documented objective evidence under Clause 8.5.2.
CAPA is not complete when action is implemented. Under ISO 13485 Clause 8.5.2, closure requires effectiveness verification supported by defined criteria, monitoring, objective evidence, and documented results.

The clause: ISO 13485 Section 8.5.2 — Corrective Action

What auditors find: CAPAs closed at implementation with no effectiveness check. Effectiveness verifications that consist of a single sentence — “action implemented, problem resolved” — with no supporting data. Criteria for effectiveness that were defined after the action was taken rather than before. The same problem recurring in a subsequent audit cycle.

Closing a CAPA without effectiveness verification is one of the most consistently cited major nonconformances in ISO 13485 audits. The standard requires that corrective actions be reviewed for effectiveness — and that review must be documented, must use defined criteria, and must be supported by evidence.

The pattern most organizations fall into is treating CAPA closure as an administrative step rather than a quality decision. Someone implements the action, marks the record complete, and moves on. The question “did this actually work?” never gets formally answered.

The fix: Effectiveness verification criteria must be established before the corrective action is implemented — not after. The criteria should be specific enough that a different person reviewing the record could objectively determine whether they were met. “No recurrence for 90 days” is a criterion. “Situation improved” is not.

For a complete breakdown of CAPA requirements under ISO 13485 Clause 8.5.2 — including the InfuTronix case study and the six mandatory data inputs under Section 8.4 — see CAPA Requirements in ISO 13485.

➡️ BSI Group ISO 13485 Training — Covers CAPA, supplier controls, management review, and all major ISO 13485 clauses. BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

Mistake 5: Risk Management Treated as a One-Time Activity

The clause: ISO 13485 Section 7.1 / ISO 14971

What auditors find: Risk files created during design and never updated. Post-market surveillance data that has no documented connection to risk management. Field failures that triggered a CAPA but never prompted a review of the corresponding risk file. Risk management plans that reference ISO 14971 but contain no evidence of post-production monitoring.

Risk management documentation under Clause 7.1 is now the top QMSR inspection finding — 25 citations in the first three months of QMSR inspection data, ahead of CAPA. That displacement reflects a systematic failure in how most organizations treat risk: as a design-phase activity rather than a lifecycle responsibility.

ISO 14971 is explicit that risk management extends across the entire product lifecycle. Post-market surveillance data, complaint trends, service reports, and CAPA findings are all risk management inputs. When those data sources exist in separate systems with no documented connection to the risk file, the risk management process is incomplete — regardless of how thorough the original risk analysis was.

The fix: Your risk management procedure should define how post-production information feeds back into risk files. When a complaint trend reaches a defined threshold, when a CAPA is opened for a field failure, when a service report pattern emerges — each of those events should trigger a documented review of the relevant risk analysis. That review should produce a documented decision: residual risk is still acceptable, or risk control measures need updating.

For the full picture of how ISO 14971 and ISO 13485 interact at the clause level, see ISO 14971 vs ISO 13485.

Mistake 6: Training Records That Prove Attendance, Not Competence

The clause: ISO 13485 Section 6.2 — Human Resources / Competence

What auditors find: Training records that show who attended a session and when, with no evidence of what was covered or whether it was understood. Competence assessments that consist of a supervisor signature with no evaluation criteria. Personnel performing quality-critical tasks without documented evidence that they are qualified to do so. New employees signed off on procedures they completed training on — but with no record of how competence was evaluated.

ISO 13485 Section 6.2 requires that personnel performing work affecting product quality are competent — and that competence is evaluated and the results are recorded. Attendance is not competence. Completing a training module is not competence. Competence is the demonstrated ability to apply knowledge and skills to produce the required outcome.

This distinction becomes a major finding when an auditor pulls the training record for someone who made a quality-critical decision and finds a sign-off sheet.

The fix: Competence evaluation needs defined criteria for each quality-critical role — what knowledge and skill is required, and how it will be evaluated. That evaluation can be a practical demonstration, a written assessment, a supervised work period with documented sign-off, or another method appropriate to the task. The key is that the record shows what was evaluated and what the result was — not just that training occurred.

If you are building competence frameworks from scratch, BSI Group’s ISO 13485 training courses include role-based competency models that align with Section 6.2 requirements. BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

Mistake 7: Internal Audits That Don’t Find Anything

The clause: ISO 13485 Section 8.2.4 — Internal Audit

What auditors find: Internal audit programs that audit the same low-risk processes repeatedly while avoiding the areas where problems actually exist. Audit reports that describe observations as “satisfactory” or “no issues found” across every clause. Internal auditors who have never issued a nonconformance. Audit findings that are consistently minor and never escalate to CAPA.

An internal audit program that finds nothing is either auditing the wrong things or auditing them incorrectly. Certification bodies and FDA investigators specifically look at the output of your internal audit program — not just whether audits were conducted on schedule. If your internal audit findings never trigger a CAPA and never surface anything your surveillance audit finds, that incongruence is a finding in itself.

ISO 13485 requires that the internal audit program take into account the status and importance of the processes to be audited and the results of previous audits. A risk-based audit program will allocate more frequency and depth to high-risk processes — CAPA, supplier controls, complaint handling, design controls — and less to lower-risk administrative processes.

The fix: Evaluate your internal audit program against what your surveillance audits and FDA inspections have actually found. If there is a consistent gap — if surveillance audits find things your internal audits missed — that gap is the finding. Your audit program needs to be harder on the areas that matter most, not easier.

If you need to develop your internal audit capability, ISOQAR offers ISO 13485 internal auditor training and certification support. ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

At this point, most quality managers preparing for their next audit should: → Cross-reference your last three internal audit reports against your last surveillance audit finding. If the surveillance audit found something your internal audits missed, that’s the gap to close first. Get the ISO 13485 Gap Assessment Checklist to run a structured review across all clauses.

Common Misconceptions About ISO 13485 QMS

ISO 13485 infographic illustrating common misconceptions about quality management systems, comparing myths versus reality around certification, QMSR alignment, and major nonconformances in medical device quality systems.
Some of the most expensive ISO 13485 mistakes begin as assumptions. Certification is not a finish line, ISO 13485 and QMSR are not identical, and a major nonconformance does not automatically mean certification loss.

“Passing initial certification means the QMS is compliant.”

Initial certification confirms that a QMS met the standard’s requirements at a specific point in time, as evaluated against a specific set of records. Surveillance audits evaluate whether the system continues to operate as documented. Organizations that build a QMS to pass initial certification and then don’t maintain it operationally consistently accumulate findings by the first surveillance audit. Certification is not a destination — it is a recurring obligation.

“ISO 13485 and FDA QMSR requirements are now the same thing.”

QMSR, which took effect February 2, 2026, aligns FDA’s device QMS requirements with ISO 13485 — but does not make them identical. Four FDA-specific requirements exist in QMSR that ISO 13485 certification alone does not cover: complaint files under 21 CFR 820.198, MDR procedures, corrections and removals, and the device master record structure. An organization that is ISO 13485 certified is not automatically QMSR compliant. The ISO 13485 Gap Assessment Checklist covers all four QMSR bridge requirements explicitly.

“A major nonconformance means we will lose certification.”

A major nonconformance means the certification body has identified a significant gap in the QMS — one that has the potential to affect product quality or patient safety. It does not automatically result in suspension or withdrawal of certification. It triggers a corrective action requirement with a defined response timeline. Organizations that respond with a documented root cause analysis and credible corrective action plan typically resolve major nonconformances without losing certification. The risk is not the finding — it is the failure to respond adequately.

Frequently Asked Questions

What is the most common ISO 13485 audit finding?

Document control failures under Section 4.2 are consistently the most common finding in surveillance audits. CAPA effectiveness verification failures and management review output gaps follow closely. Under QMSR inspections, risk management documentation under Clause 7.1 is now the leading finding.

How many nonconformances are typical in an ISO 13485 surveillance audit?

There is no typical number. A mature QMS with active internal audit and CAPA programs may receive zero nonconformances. A QMS that has been maintained administratively rather than operationally may receive multiple majors. What matters is whether findings from one audit cycle are genuinely closed before the next one.

What is the difference between a major and minor nonconformance in ISO 13485?

A major nonconformance indicates a systematic failure that has the potential to affect product quality or patient safety — or the complete absence of a required process. A minor nonconformance indicates an isolated lapse or a process weakness that does not constitute a systematic failure. Major nonconformances require a documented corrective action plan with a defined response timeline. Minor nonconformances are typically addressed at the next surveillance audit.

Can we self-declare ISO 13485 compliance without certification?

Self-declaration against ISO 13485 is not recognized in the medical device industry in the way it is sometimes used in other sectors. Customers, regulatory bodies, and OEMs expect third-party certification from an accredited body. Self-declaration provides no audit trail and no independent verification of compliance. If you are building toward certification, ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

How long does it take to fix a major nonconformance?

Certification bodies typically allow 30 to 90 days to respond to a major nonconformance with a documented corrective action plan, evidence of root cause analysis, and initial implementation evidence. Full closure — including effectiveness verification — may take longer depending on the nature of the finding. The timeline should be proposed by the organization and accepted by the certification body.

What is the best way to prepare for an ISO 13485 surveillance audit?

Run a structured internal audit against the clauses most likely to surface findings — Section 4.2 (document control), Section 5.6 (management review), Section 7.4 (supplier controls), Section 8.2.4 (internal audit), and Section 8.5.2 (CAPA). Pull a sample of CAPA records and verify that effectiveness verifications are complete. Review your management review minutes for documented outputs. Check that your approved supplier list reflects current qualification status. The ISO 13485 Gap Assessment Checklist covers all of this in 64 structured items.

Do these mistakes also apply under FDA QMSR?

Yes — and in some cases the stakes are higher. QMSR inspections evaluate every subsystem, every inspection. Document control failures, CAPA gaps, and management review deficiencies that might result in a minor nonconformance from a certification body can result in a 483 observation or warning letter from FDA. See FDA QSR vs ISO 13485 for the full regulatory alignment picture.

Free Resources

📋 Free Download: Manufacturing Compliance Checklist — ISO 9001, 14001, 45001 & OSHA — 50 items with gap scoring across all systems.

📋 Free Download: Supplier Quality Checklist — ISO 9001 Clause 8.4 — all supplier controls auditors evaluate, 45 items with scoring.

📋 Free Download: ISO 9001 Implementation Roadmap — The exact 5-phase process from gap assessment to Stage 2 audit clearance.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Not Sure What to Do Next?

→ You need the official ISO 13485:2016 standard → ANSI Webstore — Use CC2026 for 5% off. ANSI is the official U.S. distributor of ISO standards.

→ You need to assess your QMS gaps before your next audit → ISO 13485 Gap Assessment Checklist — free, 64 items

→ You need to build or rebuild QMS documentation → 9001Simplified Documentation Kits — 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

→ You need to train your team on ISO 13485 requirements → BSI Group ISO 13485 Training — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses.

→ You are ready to pursue or maintain ISO 13485 certification → ISOQAR — UKAS-accredited, one of the most recognized certification bodies in the industry.

→ You need to understand CAPA requirements in depth → CAPA Requirements in ISO 13485

→ You need to understand how risk management connects to your QMS → ISO 14971 vs ISO 13485 and What Is ISO 14971?

→ You need to understand how QMSR changed your compliance obligations → FDA QSR vs ISO 13485

→ You need to understand what ISO 13485 covers at the clause level → What Is ISO 13485?

→ You need to understand the cost of ISO 13485 certification → How Much Does ISO 13485 Cost?

→ You want to buy ISO 13485 → Buy ISO 13485

→ You want to browse all medical device standards → explore standards by compliance area

Still figuring out where to start?

If you are not ready to invest in training or documentation yet — that is normal. Most organizations take several weeks to move from identifying gaps to committing to a remediation plan.

The best next step for most organizations at this stage: → Download the free ISO 13485 Gap Assessment Checklist — it takes 20 minutes and tells you exactly where your QMS has gaps before you spend anything.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The Gap Between What Was Built and What Runs

Most ISO 13485 QMS failures are not failures of intent. The organizations that receive major nonconformances typically built their systems with genuine effort. What they built, however, was optimized for initial certification — not for the ongoing operational reality that surveillance audits and FDA inspections evaluate.

Document control systems that work at go-live drift as people find workarounds. CAPA programs that close records efficiently lose track of effectiveness. Management reviews that felt thorough produce minutes that record what was presented rather than what was decided. None of these failures are dramatic. They accumulate quietly, and they surface at the worst possible time.

The difference between a QMS that passes surveillance audits consistently and one that doesn’t is not sophistication. It is the discipline to evaluate what the system actually does — not just what the procedures say it does — on a regular basis.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

Subscribe below to stay ahead.

Subscribe

* indicates required

CAPA Requirements in ISO 13485 (2026)

CAPA under ISO 13485 is more than corrective action paperwork. Learn what auditors and FDA investigators actually evaluate, common CAPA failures, Clause 8.5 requirements, effectiveness verification expectations, and how CAPA now fits into modern QMSR inspection strategy.

What the FDA’s newest inspection data reveals about where medical device manufacturers are still getting it wrong — and how to close the gaps before your next audit.

Last Updated: May 2026

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The FDA Just Changed How It Measures Your CAPA System — And Most Manufacturers Haven’t Noticed

CAPA was the undisputed number-one FDA 483 finding for years. Not close. Not rotating with other subsystems. Every year, far and away.

That changed in 2026.

Three months of QMSR inspection data is in. Risk management documentation under Clause 7.1 now sits at number one — 25 citations. CAPA-related findings come in at 19 combined. On paper, that looks like good news. It isn’t — at least not entirely.

Here’s the nuance that matters: the inspection model changed. Under the old QSIT system, abbreviated inspections hit CAPA almost every single time. Other subsystems cycled in less frequently. CAPA’s dominance was partly an artifact of inspection structure, not a clean picture of where the industry actually struggled.

The new model looks at everything — every subsystem, every inspection. The categorization changed too. Under the old QSR, all CAPA requirements bundled into one code. Now they fragment. Two separate 8.5.2 entries already appear in the first dataset. CAPA didn’t disappear. The field just got wider.

If you’re managing a QMS for a medical device manufacturer, that means more exposure, not less.

In This Guide

  • What ISO 13485 Clause 8.5.2 actually requires — and what most procedures miss
  • The six mandatory data inputs for your CAPA process under Section 8.4
  • Why the InfuTronix case is the most instructive FDA enforcement example in recent years
  • The difference between measurement and analysis — and why confusing them causes most failures
  • How horizontal analysis works and why auditors look for it specifically
  • Common misconceptions that lead to major nonconformances
  • What to do before your next surveillance audit

Start Here (Top Resources)

🔖 Get ISO 13485:2016 → ANSI Webstore — ANSI is the official U.S. distributor of ISO standards, ensuring you receive the controlled, compliant version required for certification audits. Use coupon CC2026 for 5% off.

🔖 Get ISO 13485 training → BSI Group — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

🔖 Build your CAPA documentation → 9001Simplified — 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

🔖 Pursue or maintain ISO 13485 certification → ISOQAR — ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

Browse the Standards Library to identify which standards apply to your compliance area, or view the most widely used standards in medical devices and manufacturing.

What Is CAPA Under ISO 13485?

CAPA cycle diagram showing ISO 13485 Clause 8.5.2 corrective action and Clause 8.5.3 preventive action steps: Identify, Prevent, Monitor, Improve, Correct, Root Cause
CAPA under ISO 13485 follows a closed-loop process: identify issues, determine root cause, implement corrective action, monitor effectiveness, and prevent recurrence through continual improvement.

CAPA — Corrective and Preventive Action — is the mechanism your QMS uses to identify problems, trace them to root cause, and prevent recurrence. Under ISO 13485:2016, CAPA spans two clauses: Clause 8.5.2 (corrective action) and Clause 8.5.3 (preventive action). They operate differently and auditors evaluate them separately.

Corrective action addresses a nonconformity that has already occurred. Preventive action addresses a potential nonconformity that has not yet materialized. The distinction matters because the procedures, triggers, and documentation requirements differ between them.

ISO 13485 places CAPA in the broader context of Clause 8.5, which also covers continual improvement. But the practical application of CAPA runs deeper — it pulls from data collected across Clause 8.4 (analysis of data) and connects to management review, internal audits, and post-market surveillance. A CAPA procedure that treats the clause as standalone almost always fails at audit.

Under the QMSR (Quality Management System Regulation), which took effect February 2, 2026, FDA now explicitly harmonizes its device QMS requirements with ISO 13485. CAPA requirements that previously lived in 21 CFR Part 820.100 now map directly to ISO 13485 Clause 8.5.2. FDA expects those requirements to be met — and QMSR inspections are actively evaluating them.

What Clause 8.5.2 Actually Requires

Clause 8.5.2 sets out six specific requirements for corrective action. Each one has a documentation implication.

1. Review nonconformities — including customer complaints. This means your CAPA trigger list must include complaint data, not just internal defect records. If complaints are logged in one system and CAPA is managed in another, there needs to be a formal connection between them. Auditors check that connection.

2. Determine the causes of nonconformities — root cause analysis is not optional. Documenting “operator error” or “process deviation” without supporting evidence of how that conclusion was reached is a common major nonconformance. You need a documented methodology — 5 Whys, fishbone, fault tree — and evidence it was applied.

3. Evaluate the need for corrective action — not every nonconformity requires a CAPA. The standard requires you to evaluate and document that decision. Organizations that open a CAPA for every minor deviation create administrative burden; organizations that never document the decision to not open a CAPA create audit vulnerability.

4. Determine and implement corrective action — the action must be proportionate to the effects of the nonconformity. This means documented implementation, not just a description of what was planned.

5. Record results of corrective action — effectiveness verification is required. You must demonstrate that the action you took actually resolved the problem. A corrective action record that closes without verification evidence is not compliant.

6. Review corrective action and its effectiveness — this step loops back into your data analysis process. If the same problem recurs, your record should capture that recurrence and the updated response.

The 2026 QMSR inspection data showing two separate 8.5.2 citations reflects how inspectors are now parsing these requirements individually. A finding against root cause determination is a different citation from a finding against effectiveness verification.

At this point, most quality managers in this position should: → Confirm your CAPA procedure addresses all six elements explicitly — and that your records can demonstrate compliance with each one. Get the ISO 13485 Gap Assessment Checklist to verify your current gaps across all 13485 clauses.

The Six Data Inputs for Section 8.4

Clause 8.4 requires you to analyze data from specific sources to drive CAPA and continual improvement. The standard names six:

Data SourceWhat It Covers
FeedbackCustomer complaints, post-market surveillance data, service reports flagged by users
Product conformityInspection results, test data, nonconforming product records
Process and product trendsStatistical process control, yield trends, recurring deviations
Supplier performanceSupplier nonconformances, delivery performance, qualification data
Audit resultsInternal audit findings, certification body findings, customer audits
Service reportsField service records, repair data, failure modes reported post-delivery

Your CAPA procedure must document how data from each of these sources is collected, reviewed, and used to make CAPA decisions. The piece most manufacturers skip entirely is what experienced quality practitioners call horizontal analysis — looking across your data sources, not just within them.

The Analysis Failure: What InfuTronix Got Wrong

The InfuTronix case is the most instructive CAPA enforcement example to come out of FDA inspection activity in recent years. It illustrates the most common failure mode — and it isn’t what most people expect.

InfuTronix had a rule written directly into their CAPA procedure: ten complaints in a rolling 12-month window triggers a CAPA. Simple enough. Documented. Auditable on its face.

Between September 2020 and August 2021, they received 80 complaints reporting power issues, 31 for battery failures, and 67 for leaking administration sets. Not one CAPA was opened.

This was not a data collection failure. The complaints were logged. The threshold was documented. The system simply never connected what was being measured to what that data actually meant.

That is an analysis failure — and it is the most common one FDA finds.

Measurement gets you the number. Analysis tells you what to do with it.

ISO 13485 Section 8.4 requires both, and your procedure needs to address the full cycle: collect the data, analyze it against defined criteria, and produce a documented decision. The decision can be: open a CAPA, escalate to management review, or continue monitoring. All three are defensible. No decision — or a decision made without documentation — is not.

FDA found all of this during inspection. The warning letter that followed cited failure to establish and maintain procedures for implementing corrective action under 21 CFR 820.100(a). Under QMSR, that same finding maps directly to ISO 13485 Clause 8.5.2.

Source: FDA Warning Letter, InfuTronix LLC, June 16, 2022. Available at fda.gov.

ISO 13485 Section 8.4 infographic showing the measurement and analysis cycle with a process flow from data collection to analysis, documented decision making, and outcomes including CAPA, management review, or continued monitoring.
Measurement gets you the number. Analysis determines the response. Under ISO 13485 Section 8.4, organizations must collect data, analyze it against defined criteria, and document a defensible decision.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Horizontal Analysis: The Step Most QMS Procedures Skip

Vertical analysis — reviewing data within a single source — is what most CAPA procedures are built around. You run through complaints. You run through audit findings. You check supplier nonconformances. Each in its own silo.

Horizontal analysis means looking across those sources simultaneously — specifically for patterns that only become visible when you connect the data.

A complaint spike in Q2 means something different when it aligns with a supplier nonconformance from the same quarter. A field failure pattern means something different when it correlates with a process change implemented three months prior. A rising service report trend means something different when internal inspection data for the same product shows clean numbers — because that combination suggests the problem is post-delivery, not in-process.

These cross-source connections are where real problems get caught before FDA finds them. They are also where most QMS procedures have no documented methodology whatsoever.

Your CAPA procedure should require a formal cross-source review at defined intervals — typically aligned with management review. The review should produce a documented output: either a CAPA trigger, a decision to continue monitoring with rationale, or escalation to a different quality subsystem.

Certification bodies increasingly audit for this specifically. The question is not just “do you have a CAPA procedure?” It’s “does your analysis process look across all six data sources and produce a documented decision?”

➡️ ANSI Webstore — Get ISO 13485:2016, the standard your CAPA procedure must align with. ANSI is the official U.S. distributor of ISO standards, ensuring you receive the controlled, compliant version required for certification audits. Use coupon CC2026 for 5% off.

Common CAPA Misconceptions

“A CAPA is only needed when something goes seriously wrong.”

The standard doesn’t set a severity threshold for opening a CAPA — it requires a documented decision about whether a nonconformity warrants one. The mistake isn’t opening too many CAPAs. It’s failing to document the evaluation. Auditors don’t penalize organizations for opening few CAPAs; they penalize organizations that can’t show they evaluated the data and made a deliberate decision.

“Closing the CAPA once the action is implemented is sufficient.”

Clause 8.5.2 requires effectiveness verification — evidence that the corrective action actually resolved the problem. Closing a CAPA at implementation is one of the most consistently cited findings in ISO 13485 surveillance audits. Effectiveness verification must be documented, must use defined criteria, and must happen at a point in time when there is enough post-implementation data to draw a conclusion.

“Our CAPA system is separate from complaint handling and that’s fine.”

It isn’t. The connection between complaint data and CAPA decisions must be explicit and documented. A complaint handling procedure that logs data and a CAPA procedure that never receives it create exactly the kind of system failure the InfuTronix case illustrates. If there is no formal handoff between your complaint system and your CAPA trigger evaluation, that gap will be found.

What Auditors Look For in CAPA Reviews

Whether the auditor is from a certification body or an FDA investigator conducting a QMSR inspection, the CAPA review follows a consistent pattern. Understanding it in advance is the most effective preparation.

They start with your procedure. They read it. They look for whether it covers all six elements of Clause 8.5.2 and whether it explicitly addresses the six data inputs from Clause 8.4. Gaps in the procedure are flagged before they look at a single record.

They pull a sample of CAPA records. Typically 3–5 for a surveillance audit, more for initial certification or for-cause inspections. They are looking for: documented root cause methodology, proportionality between the action and the finding, effectiveness verification with criteria and evidence, and closure only after verification.

They look for records that should exist but don’t. This is where analysis failures surface. If complaint data shows a spike and no CAPA was opened, the auditor will ask for the documented decision that concluded no CAPA was needed. If that document doesn’t exist, that is a finding — regardless of whether the decision was actually reasonable.

They check the connection between data sources. Does your management review input include CAPA status? Does your internal audit program look at CAPA effectiveness? Does complaint data flow into your trend analysis? These connections are evaluated systematically.

They review effectiveness verifications. A CAPA closed with “action implemented — problem resolved” and no supporting data is a major nonconformance. Effectiveness verification requires defined criteria established before the action is taken, a monitoring period, and data that demonstrates the criteria were met.

ISO 13485 CAPA audit review infographic showing the key areas auditors evaluate during certification and FDA inspections, including procedures, CAPA records, missing records, data connections, and effectiveness verification.
CAPA audits follow a predictable path. Auditors review procedures, sample records, process connections, and effectiveness evidence to determine whether your system is functioning as designed.

If you are preparing for a certification audit or a QMSR inspection, the FDA QSR vs ISO 13485 (QMSR Transition Guide) is the clearest resource available on how the two frameworks now align.

If you are building CAPA procedures from scratch or rewriting existing ones, the What Is ISO 13485? pillar article covers the full clause-by-clause context you need before the documentation work begins. For a complete breakdown of how ISO 13485 and FDA QMSR requirements interact at the clause level, see ISO 9001 vs ISO 13485.

If you are under active FDA inspection pressure → Get BSI Group ISO 13485 training and ISOQAR certification support immediately. BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally. ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

ProviderWhat You GetBest For
ANSI WebstoreISO 13485:2016 official standard documentAny organization needing the controlled, compliant version of the standard
BSI GroupISO 13485 training coursesTeams preparing for implementation, audit readiness, or CAPA procedure development
9001SimplifiedQMS documentation kitsOrganizations building CAPA and QMS documentation from scratch
ISOQARISO 13485 certificationOrganizations ready to pursue or maintain certification

Most organizations at this stage need all three:

This combination covers the standard, the knowledge, and the implementation infrastructure.

Frequently Asked Questions

What does ISO 13485 require for CAPA?

ISO 13485 Clause 8.5.2 requires a documented procedure that covers reviewing nonconformities, determining root causes, evaluating the need for action, implementing corrective action proportionate to the problem, recording results, and verifying effectiveness. Preventive action under Clause 8.5.3 follows a parallel structure for potential — not actual — nonconformities.

What is the most common CAPA finding in ISO 13485 audits?

Failure to verify the effectiveness of corrective actions is consistently the most common major nonconformance in surveillance audits. The second most frequent is incomplete root cause analysis — particularly records that name a root cause without showing the methodology used to reach that conclusion.

How many CAPAs should a medical device manufacturer open per year?

There is no target number. A small manufacturer with a mature QMS might open fewer than ten CAPAs annually and pass every audit. What auditors evaluate is whether the documented decision-making process is defensible — not the volume of CAPAs opened. If you are in a situation where your data shows patterns and no CAPAs are being opened, the risk is high regardless of company size.

Does CAPA under QMSR differ from CAPA under the old QSR?

The substance is largely the same. The significant change is that QMSR now explicitly adopts ISO 13485 Clause 8.5.2 as the governing framework, and inspections evaluate every subsystem — not just CAPA, as abbreviated QSIT inspections frequently did. Two separate 8.5.2 citations already appear in early QMSR inspection data, reflecting more granular evaluation of individual requirements within the clause. Read the full FDA QSR vs ISO 13485 Transition Guide for a complete breakdown.

What is the difference between corrective action and preventive action in ISO 13485?

Corrective action (Clause 8.5.2) addresses a nonconformity that has already occurred. Preventive action (Clause 8.5.3) addresses a potential nonconformity that trend data or risk analysis suggests may occur. The distinction is more than semantic — auditors evaluate them separately, the documentation requirements differ, and the trigger criteria for each should be explicit in your procedure.

Can we use a single CAPA form for both corrective and preventive actions?

Yes — many organizations use a combined form with fields that distinguish the type of action. What matters is that the record clearly identifies whether the action is corrective or preventive, that the corresponding clause requirements are addressed, and that the effectiveness verification criteria are appropriate for the action type.

What data sources must feed our CAPA process under ISO 13485?

Clause 8.4 identifies six: feedback (including complaints), product conformity data, process and product trends, supplier performance, audit results, and service reports. Your CAPA procedure should document how each source is reviewed, at what frequency, and how that review produces documented CAPA decisions. If you are using the ISO 13485 Gap Assessment Checklist, the data analysis section will identify exactly where your current procedure has gaps.

How long do we need to keep CAPA records?

ISO 13485 Section 4.2.5 requires records to be retained for a period at least equal to the lifetime of the device, but not less than two years from the date of product release. FDA QMSR requirements align with this. For implantable devices or devices with extended service life, the retention period is typically longer and should be specified in your records control procedure.

Free Resources

📋 Free Download: Manufacturing Compliance Checklist — ISO 9001, 14001, 45001 & OSHA — 50 items with gap scoring across all systems.

📋 Free Download: Supplier Quality Checklist — ISO 9001 Clause 8.4 — all supplier controls auditors evaluate, 45 items with scoring.

📋 Free Download: ISO 9001 Implementation Roadmap — The exact 5-phase process from gap assessment to Stage 2 audit clearance.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Not Sure What to Do Next?

→ You need the official ISO 13485:2016 standard → ANSI Webstore — Use CC2026 for 5% off. ANSI is the official U.S. distributor of ISO standards.

→ You need to understand how your CAPA requirements changed under QMSR → FDA QSR vs ISO 13485 Transition Guide

→ You need to train your team on ISO 13485 CAPA requirements → BSI Group ISO 13485 Training — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses.

→ You need to build CAPA documentation from scratch → 9001Simplified Documentation Kits — 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS.

→ You are ready to pursue ISO 13485 certification → ISOQAR — ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

→ You want to assess your full ISO 13485 gaps before spending anything → ISO 13485 Gap Assessment Checklist — free, 64 items

→ You need to understand what ISO 13485 covers before addressing CAPA specifically → What Is ISO 13485?

→ You need to understand how risk management connects to CAPA → What Is ISO 14971? and ISO 14971 vs ISO 13485

→ You need to compare ISO 13485 to ISO 9001 to understand CAPA differences → ISO 9001 vs ISO 13485

→ You want to buy ISO 13485 → Buy ISO 13485

→ You want to browse all medical device standards in one place → explore sector-specific standards or browse standards by compliance area

Still figuring out where to start?

If you are not ready to purchase yet — that is normal. ISO 13485 CAPA decisions typically take weeks from first research to implementation commitment.

The best next step for most organizations at this stage: → Download the free ISO 13485 Gap Assessment Checklist — it takes 20 minutes and tells you exactly where your CAPA and QMS gaps are before you spend anything.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The Cost of an Analysis Failure

CAPA is not a form. It is not a procedure sitting in your document management system. It is the mechanism that connects everything your quality system measures to everything your quality system does about it. When that connection breaks — when data is collected, thresholds are documented, and no one asks what the numbers actually mean — FDA finds it. Certification bodies find it. And devices reach the field with problems that could have been caught.

The InfuTronix case isn’t an outlier. Organizations that receive 483 observations for CAPA failures almost always had a procedure. What they didn’t have was an analysis process that produced documented decisions. That gap is what inspection finds — and it’s the gap that costs the most to recover from after the fact.

Under QMSR, the inspection model is now broader. Every subsystem, every inspection. CAPA didn’t disappear from the top of the finding list — it fragmented into more specific citations. That means more exposure, not less.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

👉 Get updates on new standards, implementation strategies, and compliance insights 👉 Be first to access new guides, tools, and checklists

Subscribe below to stay ahead.

Subscribe

* indicates required

Buy ISO 14971:2019 — Official PDF & Print Sources (2026 Guide)

Where to buy the official ISO 14971:2019 standard, what formats are available, how much it costs, and why purchasing from an authorized source is non-negotiable for medical device risk management — including why the superseded 2007 edition still circulating online creates real certification and regulatory risk.

Where to buy the official ISO 14971:2019 standard, what formats are available, how much it costs, and why purchasing from an authorized source is non-negotiable for medical device risk management.

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

📥 Free ISO 13485 & ISO 14971 Implementation Checklist — Confirm you have every required risk management document before your first certification audit. → [Download Free Checklist]

ISO 14971 Is No Longer Optional for Medical Device Manufacturers

ISO 14971:2019 was already the international standard for medical device risk management. Since February 2, 2026, it carries additional weight: the FDA’s Quality Management System Regulation (QMSR) incorporated ISO 13485:2016 by reference — and ISO 13485 explicitly requires risk management per ISO 14971. That means ISO 14971 is now embedded in U.S. regulatory expectations for every manufacturer subject to 21 CFR Part 820.

FDA investigators operating under Compliance Program 7382.850 are expected to use the risk management file as their inspection roadmap — following risk documentation into design controls, CAPA, supplier qualification, and post-market surveillance. If your risk management program is not built on ISO 14971, that gap will surface under QMSR inspection.

This guide covers exactly where to buy the official ISO 14971:2019 standard, what formats are available, how much it costs, and what to watch out for when purchasing.

⚠️ The QMSR compliance date has passed (February 2, 2026). Organizations that have not yet integrated ISO 14971 across their quality system are operating with a gap that FDA inspectors are actively evaluating.

In This Guide

  • What ISO 14971:2019 is and what changed from the 2007 edition
  • Which edition you need — 2019 vs 2007
  • Where to buy the official standard from authorized sources
  • Available formats — PDF, print, multi-user, and bundles
  • How much ISO 14971:2019 costs
  • Who needs to purchase the standard
  • What ISO 14971 does NOT include
  • Common purchasing mistakes to avoid
  • Related standards you will also need

👉 Start Here (Top Resources)

👉 Purchase the official ISO 14971:2019 standard — the current edition for all medical device risk management programs → ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off through December 31, 2026. ANSI is the official U.S. distributor of ISO standards, ensuring you receive the controlled, compliant version required for certification audits.

👉 Purchase the required companion — ISO 13485:2016 → ISO 13485:2016 — ANSI Webstore — use coupon CC2026 for 5% off. ISO 14971 cannot be implemented in isolation — it is a required companion to ISO 13485 and must be purchased and controlled as an external document within your QMS.

👉 Save up to 50% buying both standards together → ISO Standards Packages — ANSI Webstore — the most cost-effective option for organizations purchasing ISO 14971 alongside ISO 13485 and related standards.

👉 Get ISO 13485 training covering risk management requirements → BSI Group ISO 13485 Training — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

👉 Get ISO 13485 certified with an accredited certification body → ISOQAR ISO 13485 Certification — ISOQAR is a UKAS-accredited certification body, one of the most recognized in the industry for ISO 13485 certification.

What Is ISO 14971:2019?

Feature image for an ISO 14971 guide showing medical device risk management concepts, lifecycle risk controls, and the relationship between ISO 14971, ISO 13485, and FDA QMSR requirements.
ISO 14971 is the required risk management framework for medical devices, embedding risk analysis and control throughout the product lifecycle and supporting ISO 13485 and FDA QMSR compliance.

ISO 14971:2019 — Medical Devices: Application of Risk Management to Medical Devices — is the international standard defining the process for identifying hazards associated with medical devices, estimating and evaluating associated risks, controlling those risks, and monitoring the effectiveness of those controls throughout the device lifecycle.

The standard is published by the International Organization for Standardization and is recognized globally as the baseline risk management framework for medical device manufacturers. It applies to all device classes — from Class I low-risk devices through Class III implantables — and to every organization involved in the device lifecycle: manufacturers, component suppliers, contract manufacturers, and service providers.

ISO 14971 does one thing with precision: it defines a formal, documented, lifecycle-integrated process for managing risk in medical device development and manufacturing. Nothing else in the ISO 13485 framework tells you how to manage risk — that is ISO 14971’s job.

Key updates in the 2019 edition include clarified terminology aligned with ISO/IEC Guide 63, updated requirements for risk management plan documentation, strengthened requirements for production and post-production information, and enhanced guidance on benefit-risk analysis. The 2019 edition also removed references to ALARP (As Low As Reasonably Practicable) — replacing it with a more precise framework for determining risk acceptability. For the complete breakdown of what the standard requires, see What Is ISO 14971? — Complete Guide.

ISO 14971:2019 vs ISO 14971:2007 — Which Do You Need?

SituationEdition to Purchase
New risk management program — first implementationISO 14971:2019
Currently using ISO 14971:2007 — planning updateISO 14971:2019
Pursuing ISO 13485 certificationISO 14971:2019
Subject to FDA QMSR (21 CFR Part 820)ISO 14971:2019
EU MDR technical documentationISO 14971:2019
Researching risk management before committingISO 14971:2019

The answer in every case is ISO 14971:2019. The 2007 edition has been superseded. ISO 13485:2016 references ISO 14971 — and certification bodies audit against the current edition. The QMSR regulatory expectation is built on ISO 13485:2016, which requires current-edition conformance.

If your organization is still operating a risk management program built on ISO 14971:2007, purchasing the 2019 edition and conducting a gap assessment is your first step. The changes are substantive enough that a documented gap assessment is expected before your next certification audit.

→ ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off through December 31, 2026

Where to Buy ISO 14971:2019 — Official Sources Only

ISO standards are copyrighted intellectual property. They are not available as free downloads and must be purchased from authorized distributors. Every “free ISO 14971 PDF” circulating online is an unauthorized copy — typically an outdated 2007 edition, an incomplete document, or an altered version. Using an unauthorized copy for risk management program development introduces certification risk and potential regulatory exposure simultaneously.

Certification bodies audit against the precise wording of the current official standard. A risk management file built from an outdated or incomplete copy will generate nonconformances — costing far more in audit findings and corrective action cycles than the official document.

ProviderWhat You GetPrice RangeBest ForLink
ANSI WebstoreOfficial current edition, immediate PDF delivery, audit-accepted$150–$200U.S.-based organizations — official distributor, CC2026 coupon availableBuy Here
ISO.org StoreOfficial current edition directly from publisher$158–$198International buyers outside the U.S.iso.org/store
ANSI Bundle PackageISO 14971 + ISO 13485 + related standards$300–$500Organizations purchasing multiple medical device standards — significant savingsBundle Here
Where to buy ISO standards comparison showing ANSI Webstore, ISO Store, and other resellers with pros and risks
Compare ANSI, ISO, and other sources to safely buy ISO standards for certification and compliance

ANSI Webstore is the recommended source for U.S.-based organizations. ANSI is the official U.S. distributor of ISO standards — purchasing through ANSI guarantees the current edition, complete document, licensed PDF with immediate delivery, and a recognized distributor credential accepted by all certification bodies and regulatory authorities.

→ Use coupon code CC2026 for 5% off ISO and IEC standards at the ANSI Webstore through December 31, 2026

At this point, most organizations purchasing ISO 14971 for the first time should: → Purchase the bundle including ISO 13485:2016 and ISO 14971:2019 together from ANSI Standard Packages — the savings over individual purchases typically cover the cost of training materials, and you need both documents on hand before implementation begins.

ISO 14971 Formats Available

FormatPrice RangeBest ForNotes
Single-user PDF$150–$200Individual quality managers and risk managersImmediate delivery, searchable — cannot be shared simultaneously
Printed copy$170–$220Risk management teams, controlled document environmentsUseful for annotating during implementation — slightly higher cost
Multi-user licenseContact ANSIOrganizations with multiple simultaneous usersRequired if multiple team members need access at the same time
Bundle with ISO 13485$300–$500Any organization implementing ISO 13485Best value — you need both; bundle saves 30–50% vs individual

Single-user PDF is the most common choice for quality managers implementing risk management programs. It is immediately accessible after purchase, searchable by clause number, and sufficient for a single implementer building the risk management framework.

Important licensing rule: A single-user PDF license cannot legally be shared across your organization. If your risk management team, design engineers, and regulatory affairs personnel all need simultaneous access, a multi-user license is required. Sharing a single-user PDF via email or shared drive violates the license terms — a detail that is often overlooked during implementation and can create legal exposure.

If you are implementing both ISO 14971 and ISO 13485, purchase them as a bundle. You will need both on hand from day one of your gap assessment — and the bundle consistently saves more than the coupon alone.

→ ISO Standards Packages — Save up to 50%

How Much Does ISO 14971:2019 Cost?

ItemTypical PriceNotes
Single-user PDF$150–$200Standard purchase from ANSI Webstore
Printed copy$170–$220Physical copy for reference
Multi-user licenseVariesContact ANSI for pricing
Bundle: ISO 14971 + ISO 13485$300–$500Saves 30–50% vs individual purchase
Bundle: ISO 14971 + ISO 13485 + ISO 13485 collection$350–$600Full medical device standards set

Use coupon CC2026 for 5% off at ANSI through December 31, 2026 → Apply at ANSI

In the context of total ISO 13485 certification costs — which range from $15,000 to $100,000+ for most organizations — the ISO 14971 standard purchase is the lowest-cost line item in your entire budget. It is also the one with the highest leverage on audit outcomes. A risk management file built from the correct current edition is foundational. Everything else in your QMS depends on it.

For the complete ISO 13485 certification cost breakdown, see How Much Does ISO 13485 Cost?

Who Needs to Purchase ISO 14971?

ISO 14971:2019 must be purchased by anyone responsible for building, implementing, auditing, or maintaining a medical device risk management program. Specifically:

Risk managers and quality managers building a risk management program from scratch or updating from ISO 14971:2007 — the standard is the only authoritative source for what the process requires. Implementing from a summary or training slide deck rather than the official document is one of the most common reasons risk management files fail certification audits.

Design engineers and product development teams at organizations with design responsibility — risk management under ISO 14971 begins at design input and runs through every design stage. Engineers performing hazard analysis, risk estimation, and risk control selection need the standard directly.

Internal auditors conducting ISO 13485 internal audits — you cannot audit risk management effectiveness against a standard you have not read. Clause 7.1, 7.3, and the full risk management integration requirements across ISO 13485 require familiarity with ISO 14971 clause requirements.

Regulatory affairs professionals preparing FDA QMSR compliance documentation or EU MDR technical files — both regulatory frameworks expect ISO 14971 conformance, and regulatory submissions are evaluated against the standard’s exact requirements.

Organizations currently certified to ISO 14971:2007 planning their 2019 edition gap assessment — purchasing the 2019 edition is step one. The gap assessment cannot be conducted without it.

If you are at this stage:

If you are a quality manager building your first ISO 14971-based risk management program → purchase ISO 14971:2019 and ISO 13485:2016 together from ANSI Standard Packages, then enroll your team in BSI Group ISO 13485 Training before documentation development begins.

If you are currently ISO 14971:2007 compliant and planning your 2019 transition → purchase the 2019 edition, conduct a documented gap assessment focused on the ALARP removal, updated risk acceptability criteria, and post-production information requirements, and update your risk management plan before your next surveillance audit.

If you are a component supplier entering the medical device supply chain → your OEM customer will require ISO 14971-aligned risk management as part of supplier qualification. Purchase the standard before your first supplier audit.

What ISO 14971 Does NOT Include

Professional infographic illustrating what ISO 14971 does not include, highlighting exclusions such as device-specific risk acceptability criteria, clinical evaluation, implementation templates, and IEC 62304 software lifecycle requirements.
Understanding what ISO 14971 does not include is just as important as understanding what it does. The standard defines the risk management framework, but organizations remain responsible for implementation methods, clinical evaluation activities, and device-specific risk decisions.

Understanding what you are not buying is as important as understanding what you are.

ISO 14971 does not provide device-specific risk acceptability criteria. The standard defines the process for determining risk acceptability — it does not tell you what the acceptable residual risk level is for your specific device. That determination is your organization’s responsibility, informed by applicable regulations, clinical data, and the state of the art.

ISO 14971 does not replace clinical evaluation. Risk management and clinical evaluation are complementary but distinct requirements under ISO 13485 and EU MDR. ISO 14971 covers the risk management process — clinical evaluation has its own standards and guidance documents.

ISO 14971 does not provide implementation templates. The standard defines requirements — your organization must build the risk management plan, hazard identification tools, risk estimation worksheets, and risk control documentation. For ready-to-use ISO 13485 QMS documentation including risk management templates, see 9001Simplified Documentation Kits. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

ISO 14971 does not satisfy IEC 62304. Organizations developing medical device software need IEC 62304 — software lifecycle processes for medical devices — in addition to ISO 14971. The two standards work together but address different scopes.

Common Purchasing Mistakes to Avoid

Buying ISO 14971:2007 instead of ISO 14971:2019. The 2007 edition is superseded. Third-party sellers frequently carry outdated editions without clear disclosure. Always verify the edition year before completing a purchase. If a price seems unusually low, check the edition.

Downloading unauthorized copies. Every “free ISO 14971 PDF” found through a search engine is an unauthorized copy — typically the 2007 edition, an incomplete document, or an altered version. Using it for risk management program development introduces certification risk. The standard costs $150–$200. A major nonconformance at Stage 2 costs multiples of that in re-audit fees and timeline delays.

Purchasing without checking the edition date. Even on legitimate platforms, searching “ISO 14971” can surface the 2007 edition alongside the 2019 edition. Always confirm “ISO 14971:2019” before adding to cart.

Treating ISO 14971 as a design-only requirement. The most common QMSR and ISO 13485 gap is a risk management program that lives only in design files. Under QMSR, risk-based thinking extends across supplier qualification, production processes, CAPA, complaint handling, and post-market surveillance. Purchasing the standard is step one — reading Clauses 3, 8, and 9 in their entirety is what reveals the full scope of implementation required.

Sharing a single-user PDF with your team. A single-user license covers one user. Sharing via email or shared drive violates the license terms. If multiple team members need simultaneous access, purchase a multi-user license.

Purchasing ISO 14971 without ISO 13485. ISO 14971 does not stand alone in a medical device QMS context. It is a required companion to ISO 13485 — and you need both documents to implement either correctly. Purchase them together.

At this point, most organizations who have identified they need ISO 14971 should: → Purchase the ISO Standards Bundle including ISO 14971:2019 and ISO 13485:2016 together — this is the lowest-cost, most operationally complete starting point for any medical device risk management implementation.

Why Organizations Delay This — And What It Costs Them

The most common reason manufacturers delay purchasing ISO 14971 and building a compliant risk management program is the belief that it can be addressed “during the certification project.”

Here is what consistently happens instead:

Organizations that arrive at Stage 1 of their ISO 13485 certification audit without a documented, ISO 14971-based risk management program receive a major nonconformance — delaying Stage 2 by 3–6 months and adding $5,000–$15,000 in re-audit fees and consultant costs. The risk management file is one of the first things a certification body auditor reviews.

Under QMSR, the stakes are higher. FDA investigators under CP 7382.850 use the risk management file as their inspection roadmap. An absent or inadequate risk management program does not just generate a finding — it gives the inspector a thread to pull through design controls, CAPA, and supplier qualification simultaneously.

The organizations that move first — purchasing the standard, conducting the gap assessment, and building ISO 14971 integration across the QMS before the certification audit — consistently report shorter audit cycles, fewer findings, and lower total certification costs. The ones that treat risk management as a later step discover that it is actually the foundation everything else is audited against.

📥 Free ISO 13485 & ISO 14971 Implementation Checklist — Identify your top 5 risk management gaps before your certification audit. → [Download Free Checklist]

ISO 14971 does not operate in isolation. Organizations building a medical device QMS will need these companion standards:

StandardPurposeRelationship to ISO 14971Where to Buy
ISO 13485:2016Medical device QMS requirementsRequires ISO 14971 throughout — cannot be implemented without itANSI Webstore
ISO/TR 24971:2020Guidance on ISO 14971 applicationNon-mandatory companion — practical guidance on applying ISO 14971 requirementsANSI Webstore
IEC 62304Software lifecycle for medical devicesComplements ISO 14971 for software risk managementANSI Webstore
ISO 9001:2015General QMS foundationUseful reference for organizations building ISO 13485 on an existing ISO 9001 foundationANSI Webstore

Organizations implementing ISO 13485 for the first time should prioritize: ISO 14971:2019 + ISO 13485:2016. These two documents together define what your QMS must do and how risk must be managed within it.

→ Save up to 50% on ISO Standards Packages — ANSI Webstore

Frequently Asked Questions

What is ISO 14971:2019?

ISO 14971:2019 is the current edition of the international standard for risk management for medical devices. It defines the process for identifying hazards associated with medical devices, estimating and evaluating risks, implementing risk controls, and monitoring effectiveness throughout the device lifecycle. It is a required companion standard to ISO 13485:2016.

Is ISO 14971 required for ISO 13485 certification?

Yes — ISO 13485 explicitly requires risk management per ISO 14971 throughout the QMS. Certification bodies audit risk management processes against ISO 14971 requirements. Under the FDA’s QMSR, ISO 14971 conformance is embedded in U.S. regulatory expectations for all manufacturers subject to 21 CFR Part 820.

What is the difference between ISO 14971:2019 and ISO 14971:2007?

The 2019 edition clarified terminology, updated the risk acceptability framework by removing ALARP references, strengthened post-production information requirements, and enhanced benefit-risk analysis guidance. Any organization currently using the 2007 edition should conduct a gap assessment and transition to the 2019 edition before their next certification audit.

Where is the best place to buy ISO 14971:2019?

The ANSI Webstore is the recommended source for U.S. organizations — it is the authorized U.S. distributor for ISO standards and guarantees the current edition. Use coupon CC2026 for 5% off through December 31, 2026. → ISO 14971:2019 — ANSI Webstore

Can I share my ISO 14971 PDF with my design team?

No — a single-user PDF license cannot be shared simultaneously. If multiple team members need access at the same time, purchase a multi-user license or individual copies. Physically sharing a printed copy sequentially is permitted.

Do I need both ISO 14971 and ISO 13485?

Yes. ISO 14971 and ISO 13485 are required companions — neither can be fully implemented without the other. ISO 13485 defines your QMS framework; ISO 14971 defines how risk must be managed within it. Purchase them together for the best value. → ISO Standards Packages — Save up to 50%

Does ISO 14971 apply to software?

ISO 14971 applies to risk management for medical devices including software as a medical device (SaMD). For the software development lifecycle specifically, IEC 62304 is the companion standard. Risk management under ISO 14971 and software lifecycle management under IEC 62304 are intended to be implemented together.

What is ISO/TR 24971?

ISO/TR 24971:2020 is a technical report providing guidance on the application of ISO 14971. It is not a requirement — it is a non-mandatory companion document offering practical interpretation and application examples. Organizations new to ISO 14971 often find it valuable alongside the standard itself.

How much does ISO 14971:2019 cost?

A single-user PDF typically costs $150–$200 from the ANSI Webstore. Use coupon CC2026 for 5% off through December 31, 2026. Bundles including ISO 14971 with ISO 13485 offer savings of 30–50% compared to individual purchases.

📥 Free Resources

👉 Free ISO 13485 & ISO 14971 Implementation Checklist — Verify every required risk management document is in place before your certification audit 👉 Manufacturing Compliance Checklist — Assess your current compliance status across quality, environmental, and safety requirements 👉 Supplier Quality Checklist — Supplier qualification requirements applicable to medical device supply chains

Not Sure What to Do Next?

◆ You need the official ISO 14971:2019 standard → ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off through December 31, 2026

◆ You need the required companion standard ISO 13485:2016 → ISO 13485:2016 — ANSI Webstore — use coupon CC2026 for 5% off

◆ You want to save buying both standards together → Save up to 50% on ISO Standards Packages — ANSI Webstore

◆ You need ISO 13485 training covering risk management requirements → BSI Group ISO 13485 Training

◆ You are ready to pursue ISO 13485 certification → ISOQAR ISO 13485 Certification

◆ You want to understand what ISO 14971 requires → What Is ISO 14971? — Complete Guide

◆ You want to understand the full FDA QMSR transition → FDA QSR vs ISO 13485: The Complete QMSR Transition Guide

◆ You want to understand how ISO 9001 and ISO 13485 differ → ISO 9001 vs ISO 13485 — Key Differences

◆ You want to understand what ISO 13485 requires → What Is ISO 13485? — Complete Guide

◆ You want to understand certification costs → How Much Does ISO 13485 Cost? → ISO Certification Cost Calculator

◆ You want to choose the right certification body → Best ISO Certification Bodies — Ranked & Reviewed

Still figuring out where to start?

If you are not ready to purchase yet — that is normal. ISO 14971 implementation decisions typically take 2–4 weeks from first research to commitment as organizations assess their current risk management program against what certification auditors expect.

The best next step for most organizations at this stage: → Download the free ISO 13485 & ISO 14971 Implementation Checklist — it takes 20 minutes and tells you exactly where your gaps are before you spend anything.

📥 [Download Free Checklist]

The Standard That Makes Everything Else Auditable

ISO 14971 is not a box to check. It is the document that makes every other part of your medical device QMS auditable — design controls, CAPA, supplier qualification, complaint handling, and post-market surveillance all connect back to the risk management file when a certification auditor or FDA investigator starts pulling threads.

Organizations that purchase the official standard, read it completely, and build their risk management program against its actual requirements consistently report fewer findings, shorter audit cycles, and lower total certification costs. The ones that work from summaries, training slides, or outdated editions discover those shortcuts at the worst possible moment.

The standard costs $150–$200. A failed Stage 2 audit costs multiples of that. Buy the official edition.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

👉 Get updates on new standards, implementation strategies, and compliance insights 👉 Be first to access new guides, tools, and checklists

Subscribe below to stay ahead.

Subscribe

* indicates required

ISO 14971 vs ISO 13485: What’s the Difference and How Do They Work Together? (2026 Guide)

ISO 13485 requires risk management throughout the quality management system. ISO 14971 defines exactly how that risk management must be conducted. This guide covers the precise differences between the two standards, where they integrate clause by clause, and what the FDA’s QMSR means for both.

Last Updated: May 2026

ISO 13485 requires risk management. ISO 14971 defines how to do it. Understanding the precise relationship between these two standards — and what it means under the FDA’s QMSR — is the difference between a QMS that holds up under inspection and one that doesn’t.

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

📋 Free Download: ISO 13485 Gap Assessment Checklist Identify your compliance gaps before your first audit — 64 items across 7 sections including ISO 14971 risk management integration and all four FDA QMSR bridge requirements. Download Free Checklist

ISO 13485 Tells You to Manage Risk. ISO 14971 Tells You How.

That single sentence is the most important thing to understand about the relationship between these two standards — and it’s the part most manufacturers either misread or oversimplify.

ISO 13485:2016 is a quality management system standard. It requires risk-based thinking throughout the QMS — in design and development planning, production controls, supplier controls, complaint handling, and post-market surveillance. It references ISO 14971 in a note to Clause 7.1. But it does not specify how risk management must be conducted. It tells you risk management is required. ISO 14971 tells you how to do it.

ISO 14971:2019 is a risk management standard. It provides the structured framework — hazard identification, risk estimation, risk evaluation, risk control, overall residual risk evaluation, risk management review, and post-production monitoring — that gives ISO 13485’s risk management requirements their practical content.

Together they form the twin pillars of medical device quality and safety assurance. Neither is complete without the other for a manufacturer operating in any major regulated market. And under the FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, the relationship between the two standards now carries federal regulatory weight.

In This Guide

  • What ISO 13485 covers and what it requires on risk
  • What ISO 14971 covers and what it adds
  • The key differences between the two standards
  • The precise points where ISO 13485 references ISO 14971
  • The important nuance about whether ISO 14971 is truly mandatory
  • How the FDA QMSR changes the practical answer to that question
  • How to implement both standards together
  • Which standard to buy first and why
  • Frequently asked questions

✅ Start Here (Top Resources)

📋 Buy ISO 13485:2016 (official standard) → ANSI Webstore — ANSI is the official U.S. distributor of ISO standards, ensuring you receive the controlled, compliant version required for certification audits. Use coupon CC2026 for 5% off.

📋 Buy ISO 14971:2019 (required companion) → ANSI Webstore — Purchase both standards together for maximum savings. Use coupon CC2026 for 5% off.

📋 Save buying both standards → ISO Standards Bundles — Up to 50% Off — Purchasing ISO 13485 and ISO 14971 as a bundle through the ANSI Webstore saves significantly compared to individual purchases.

📋 Get ISO 13485 trained before implementation → BSI Group ISO 13485 Training — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

📋 Get ISO 13485 certified → ISOQAR ISO 13485 Certification — ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

What Is ISO 13485?

Medical device quality management infographic showing ISO 13485 certification concept with medical equipment and headline “What Is ISO 13485? Complete Guide (2026)”.
ISO 13485 defines the quality management system requirements for medical device manufacturers, focusing on regulatory compliance, risk management, and consistent product quality.

ISO 13485:2016 is the international standard for quality management systems specific to the medical device industry. It specifies requirements for a QMS that enables an organization to consistently design, develop, produce, and deliver safe and effective medical devices and related services.

ISO 13485 is used as the baseline QMS framework by regulatory authorities and certification bodies in most major medical device markets — including Health Canada, the EU MDR, MDSAP, and since February 2, 2026, the FDA’s QMSR under 21 CFR Part 820.

ISO 13485 covers the full scope of quality management system requirements:

  • Context of the organization and QMS scope
  • Management responsibility, quality policy, and management review
  • Resource management — personnel, infrastructure, and work environment
  • Product realization — design and development, purchasing, production, and service provision
  • Measurement, analysis, and improvement — internal audits, complaint handling, CAPA, and corrective action

What ISO 13485 requires on risk: ISO 13485 requires risk-based thinking throughout the quality management system. Risk management must be planned as part of product realization (Clause 7.1), integrated into design and development (Clause 7.3), applied to supplier controls (Clause 7.4), and fed by post-market surveillance feedback (Clause 8.2). The standard references ISO 14971 explicitly in its Clause 7.1 note and implicitly throughout its design and development requirements.

What ISO 13485 does not do is specify the methodology for risk management. It does not define how to identify hazards, estimate risks, evaluate acceptability, or control residual risk. That is what ISO 14971 does.

For a complete overview of ISO 13485 requirements, see What Is ISO 13485? Complete Guide.

What Is ISO 14971?

ISO 14971:2019 is the international standard for the application of risk management to medical devices. It provides the structured methodology — terminology, principles, and process — for identifying hazards, estimating and evaluating risks, implementing risk controls, and monitoring risk throughout the entire device lifecycle.

ISO 14971 covers:

  • Risk management planning — scope, lifecycle phases, risk acceptability criteria
  • Hazard identification — under both normal use and fault conditions
  • Risk estimation — probability of harm and severity of harm
  • Risk evaluation — comparison against acceptability criteria
  • Risk control — priority order: design, protective measures, information for safety
  • Evaluation of overall residual risk — including benefit-risk analysis where required
  • Risk management review — pre-release review with identified reviewers
  • Production and post-production information — systematic feedback into the risk management file

What ISO 14971 adds beyond ISO 13485: While ISO 13485 says risk management is required throughout the QMS, ISO 14971 specifies exactly how that risk management must be structured, documented, and maintained. The Risk Management File (RMF) — the central documentation output of the ISO 14971 process — is the evidence base that demonstrates a manufacturer has systematically identified hazards, evaluated risks, implemented controls, and monitored effectiveness.

For a complete overview of ISO 14971 requirements, see What Is ISO 14971? Risk Management for Medical Devices Explained.

Feature image for an ISO 14971 guide showing medical device risk management concepts, lifecycle risk controls, and the relationship between ISO 14971, ISO 13485, and FDA QMSR requirements.
ISO 14971 is the required risk management framework for medical devices, embedding risk analysis and control throughout the product lifecycle and supporting ISO 13485 and FDA QMSR compliance.

ISO 14971 vs ISO 13485 — Key Differences

ElementISO 13485:2016ISO 14971:2019
Standard typeQuality management system standardRisk management standard
PurposeDefine QMS requirements for medical device manufacturersDefine the risk management process for medical devices
ScopeEntire quality management systemRisk management specifically
Risk coverageRequires risk-based thinking throughout QMSSpecifies how risk management must be conducted
Key outputCertified, compliant QMSRisk Management File (RMF)
CertificationCertifiable — third-party certification availableNot certifiable on its own
Published byISO Technical Committee 210 (ISO/TC 210)ISO Technical Committee 210 (ISO/TC 210)
Current editionISO 13485:2016ISO 14971:2019
Applies toManufacturers, suppliers, contract manufacturersAll organizations involved in device lifecycle
Risk methodologyNot specifiedSix-step structured process
Hazard analysisReferenced but not detailedDefined in detail
Risk Management FileNot specifiedRequired
Benefit-risk analysisNot addressedRequired when overall residual risk is unacceptable
Post-production monitoringAddressed through complaint handling and feedbackExplicitly required as ongoing RMF input
QMSR statusIncorporated by reference into 21 CFR Part 820Expected framework; referenced through ISO 13485

Best for:

  • ISO 13485: Any organization that designs, manufactures, or supplies medical devices and needs a certified quality management system
  • ISO 14971: The same organizations — it provides the risk management methodology that ISO 13485’s requirements assume is in place

Where ISO 13485 References ISO 14971

Infographic mapping ISO 13485 clauses to corresponding ISO 14971 risk management requirements, showing how quality management processes trigger risk management activities across the medical device lifecycle.
ISO 13485 establishes quality system requirements, while ISO 14971 provides the risk management framework that connects planning, design, purchasing, feedback, and improvement activities throughout the medical device lifecycle.

ISO 13485 references ISO 14971 at specific points throughout its clause structure. Understanding exactly where these references occur is critical for building a compliant integrated system.

Clause 7.1 — Planning of Product Realization

Clause 7.1 requires that risk management activities be planned as part of product realization. The note to this clause states: “Further information can be found in ISO 14971.” This is the most direct reference to ISO 14971 in the standard.

Clause 7.3 — Design and Development

The design and development requirements of ISO 13485 are where ISO 14971 integration is most intensive. Design inputs must include risk management outputs. Design verification and validation activities must address risks. The Design and Development File (DDF) must reference risk management records.

Clause 7.4 — Purchasing

ISO 13485 Clause 7.4 requires that purchasing controls be proportionate to the risk the external provider poses to the finished device. The extent of supplier qualification, incoming inspection, and monitoring is determined by risk — which requires a risk framework to apply.

Clause 8.2 — Monitoring and Measurement

Post-market surveillance and complaint handling data collected under Clause 8.2 must feed back into the risk management process. ISO 14971 Clause 11 (Production and Post-Production Information) specifies how this information must be systematically reviewed and how it triggers updates to the Risk Management File.

Clause 8.5 — Improvement

CAPA activities under Clause 8.5 must consider risk. Significant quality failures identified through corrective action must evaluate whether the risk management file needs to be updated — connecting the two standards at the improvement level of the QMS.

At this point, most organizations beginning ISO 13485 implementation should:

📋 Purchase both ISO 13485:2016 and ISO 14971:2019 together as a bundle — the clause-by-clause integration means implementing one without the other creates immediate documentation gaps that auditors will identify.

→ ISO Standards Bundle — ANSI Webstore — Save up to 50% purchasing both standards together

Is ISO 14971 Actually Mandatory Under ISO 13485?

This is one of the most debated questions in the medical device quality community, and the honest answer is more nuanced than most articles present.

The technical answer: ISO 14971 is not formally mandated by ISO 13485. The reference in Clause 7.1 is a note — informative guidance, not a normative requirement. A manufacturer could theoretically implement a risk management process using a different methodology and still demonstrate conformance to ISO 13485’s risk-based requirements.

The practical answer: In the real world, ISO 14971 is effectively mandatory for any organization pursuing ISO 13485 certification or operating in regulated markets. Here’s why:

Certification bodies expect it. When a UKAS-accredited certification body audits your ISO 13485 QMS, the auditors evaluating your risk management program will be assessing it against the ISO 14971 framework — because that is the internationally recognized methodology for medical device risk management. A risk management program that doesn’t follow ISO 14971’s structure will face significant findings regardless of the technical argument about normative versus informative references.

Regulatory bodies reference it. The EU MDR, Health Canada, TGA, and MDSAP all reference ISO 14971 as the expected risk management framework. Operating without it creates regulatory exposure in every major market.

FDA QMSR changes the equation significantly — which brings us to the most important development of 2026.

The QMSR Changes the Practical Answer

The FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, incorporated ISO 13485:2016 by reference into 21 CFR Part 820. Since ISO 13485 explicitly references ISO 14971, that reference now carries federal regulatory weight.

Under the FDA’s new inspection program — Compliance Program 7382.850 — FDA investigators are expected to start inspections by reviewing the risk management file and following risk documentation into other quality system areas. The risk management file is the inspection roadmap. If your risk management program is not structured against ISO 14971, your risk management file will not hold up under that inspection approach.

Additionally, the QMSR extended risk management expectations beyond design controls — where the old QSR concentrated them — to the entire quality system. This is precisely what ISO 14971 requires: risk management planning, hazard identification, risk control, and post-production monitoring integrated across the device lifecycle, not just in the design phase.

The bottom line under QMSR: Whether or not ISO 14971 is technically mandatory in the normative sense of ISO 13485, it is the framework FDA investigators will use to evaluate your risk management program. Operating without it under the current inspection regime is an inspection liability.

⚠️ QMSR effective February 2, 2026: If your risk management program is not built on the ISO 14971 framework, this is your highest-priority gap for QMSR compliance.

For the complete QMSR transition guide, see FDA QSR vs ISO 13485 — The Complete QMSR Transition Guide.

How the Two Standards Work Together in Practice

The integration of ISO 13485 and ISO 14971 is not a separate parallel process — it is woven into how the QMS functions. Here is how the two standards interact at each stage of the device lifecycle:

Concept and Planning Stage

ISO 13485 Clause 7.1 requires risk management to be planned as part of product realization. ISO 14971 provides the Risk Management Plan — the document that defines scope, lifecycle phases, risk acceptability criteria, and the methods that will be used throughout the device’s life.

Design and Development

ISO 13485 Clause 7.3 requires design inputs to include risk management outputs and design outputs to be reviewed against inputs. ISO 14971 provides hazard identification and risk analysis — the outputs of which flow directly into design input requirements, design verification criteria, and design validation protocols.

Purchasing and Supplier Controls

ISO 13485 Clause 7.4 requires supplier controls proportionate to supplier risk. ISO 14971’s risk framework defines what “risk” means in this context — the severity and probability of harm that could result from supplier failures. Risk level drives supplier classification, incoming inspection intensity, and qualification requirements.

Production

ISO 13485 Clause 7.5 requires controlled production conditions and validation of special processes. Risk management under ISO 14971 determines which processes require validation (those where outputs cannot be fully verified) and what monitoring is required during production.

Post-Market Surveillance and CAPA

ISO 13485 Clause 8.2 requires systematic collection of post-market information. ISO 14971 Clause 11 requires that production and post-production information be systematically reviewed and fed back into the risk management file. When complaint data or CAPA findings reveal new hazards or indicate that risk estimates were incorrect, the Risk Management File must be updated.

This is where the most common gap exists in practice: organizations that treat risk management as a design-phase deliverable and do not maintain the connection between post-market data and the risk management file. Under QMSR, this gap is visible to FDA investigators within the first day of an inspection.

📋 Free Download: ISO 13485 Gap Assessment Checklist Section 6 covers ISO 14971 risk management integration specifically — risk management plan requirements, RMF structure and completeness, post-production feedback, and QMSR inspection implications. Download Free Checklist

The Risk Management File — Where They Intersect Most Clearly

Infographic comparing ISO 9001 risk-based thinking with ISO 13485 and ISO 14971 medical device risk management requirements using an integrated Venn diagram layout.
Both standards require risk management — but the depth and formality differ significantly. ISO 9001 uses general risk-based thinking, while ISO 13485 requires formal medical device risk management aligned with ISO 14971 throughout the product lifecycle.

The Risk Management File (RMF) is the single most important integration point between ISO 13485 and ISO 14971. It is the documentation output of the ISO 14971 process, and it is the record that connects risk management to every other element of the ISO 13485 QMS.

The RMF is not a single document. It is an organized collection of records that includes:

  • Risk Management Plan — scope, lifecycle phases, acceptability criteria, methodology
  • Risk analysis records — hazard identification, risk estimation
  • Risk evaluation records — comparison against acceptability criteria
  • Risk control records — selected measures, implementation records, verification
  • Overall residual risk evaluation — benefit-risk analysis where required
  • Risk Management Review — pre-release review with identified reviewers
  • Post-production information records — systematic review of real-world performance data

Under ISO 13485, the DDF (Design and Development File) must contain or reference risk management records. Under the QMSR and CP 7382.850, the RMF is where FDA investigators begin their inspection — tracing risk documentation into design controls, CAPA, complaint handling, and post-market surveillance.

A Risk Management File that was completed at device release and has not been updated since is one of the most common and most significant findings under the current inspection approach. The RMF is a living document. It must be updated throughout the device’s commercial life as post-production information is gathered and evaluated.

If your organization is already ISO 13485 certified and is assessing QMSR readiness, the current state of your Risk Management File is the single most important thing to evaluate first.

At this point, most organizations preparing for QMSR inspection should:

📋 Conduct a formal review of whether your Risk Management File has been updated since device release — and whether post-market complaint and CAPA data is systematically feeding into it. This is the highest-frequency inspection gap under CP 7382.850.

From the Shop Floor

After 25 years in heavy industrial manufacturing and quality systems, the most consistent pattern I see when organizations implement both ISO 13485 and ISO 14971 is this: they implement risk management well during design and development, and then they stop.

The Risk Management File is completed before device release. The risk management review is signed off. The certification audit passes. And then for the next three years, every complaint, every CAPA, every production nonconformance is handled in its own system — with no connection back to the risk management file that is supposed to be the living record of everything known about how the device can cause harm.

Three years later, an FDA investigator arrives under CP 7382.850 with the risk management file as their starting point. They trace a complaint about device malfunction into the CAPA system. They find a corrective action that was opened and closed. They look for the connection back to the risk management file — the evaluation of whether this complaint revealed a new hazard or indicated that an existing risk estimate was incorrect. The connection doesn’t exist.

That is not an ISO 13485 finding. It is not an ISO 14971 finding. It is a QMSR finding, because under the QMSR that connection is an expected element of a functioning integrated quality and risk management system.

The organizations that handle this well are the ones that treat the RMF update as a standing agenda item in management review — not a corrective action triggered by an audit finding. Post-market data goes into the RMF review process because the system requires it, not because an investigator asked for it.

That is what the integration of ISO 13485 and ISO 14971 is supposed to produce. It is also what separates manufacturers who pass inspections from those who merely survive them.

Which Standard Do You Buy First?

Both ISO 13485 and ISO 14971 are required for any serious medical device quality management implementation. The practical question is which to acquire and read first.

Buy ISO 13485 first if your organization is beginning the certification journey. ISO 13485 defines the overall QMS framework — understanding its requirements first gives you the context for understanding where and why ISO 14971 integrates.

Buy ISO 14971 immediately after — or together as a bundle. You cannot build a compliant risk management program from summaries or paraphrases. Both standards must be purchased, controlled as external documents within your QMS (as required under QMSR), and read by the people building your system.

For a complete overview of available medical device standards, see the Standards Library — Medical Devices Section.

The bundle option saves significantly. The ANSI Webstore offers the ISO 13485 and ISO/TR 14969 Quality Management Systems Medical Devices Package which includes both documents together at a meaningful discount versus individual purchases.

📋 ISO 13485:2016 — ANSI Webstore — use coupon CC2026 for 5% off

📋 ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off

📋 ISO Standards Bundle — Save up to 50%

Frequently Asked Questions

What is the main difference between ISO 14971 and ISO 13485?

ISO 13485 is a quality management system standard that defines what a medical device manufacturer’s QMS must cover — including the requirement that risk management be applied throughout the system. ISO 14971 is a risk management standard that defines how risk management must be conducted — the six-step process, the required documentation, and the Risk Management File structure. ISO 13485 requires risk management. ISO 14971 specifies how to do it.

Is ISO 14971 required if you have ISO 13485?

ISO 14971 is not formally mandated by ISO 13485’s normative requirements — the reference in Clause 7.1 is a note, not a normative requirement. However, certification bodies evaluate risk management programs against the ISO 14971 framework, and under the FDA’s QMSR (effective February 2, 2026), risk management expectations now carry federal regulatory weight. For practical purposes, ISO 14971 is effectively required for any organization pursuing ISO 13485 certification or operating in regulated markets.

Can you be certified to ISO 14971?

No. ISO 14971 is not a certifiable standard — there is no third-party certification to ISO 14971 itself. ISO 13485 is the certifiable standard. However, ISO 13485 certification implicitly requires that risk management is conducted in a way consistent with ISO 14971, since that is the framework certification bodies evaluate against.

Which came first — ISO 13485 or ISO 14971?

Both standards have long histories. ISO 14971 was first published in 2000, with major revisions in 2007 and 2019. ISO 13485 was first published in 1996, revised in 2003, and again in 2016. The 2016 edition of ISO 13485 was developed with the intent of aligning more closely with the 2012 draft of ISO 14971, ensuring stronger integration between the two standards.

Does ISO 14971 apply to software as a medical device?

Yes. ISO 14971:2019 explicitly applies to Software as a Medical Device (SaMD). The companion document ISO/TR 24971 provides specific guidance on applying ISO 14971 to software, including cybersecurity risk considerations.

How does the QMSR affect the relationship between ISO 13485 and ISO 14971?

The QMSR (effective February 2, 2026) incorporated ISO 13485 by reference into 21 CFR Part 820. Since ISO 13485 references ISO 14971, that reference now carries federal regulatory weight. FDA investigators under the new Compliance Program 7382.850 start inspections with the risk management file — which is the primary output of the ISO 14971 process. The QMSR also extended risk management expectations across the entire QMS rather than concentrating them in design controls as the old QSR did.

What is the Risk Management File and which standard requires it?

The Risk Management File (RMF) is the organized collection of records that documents all risk management activities for a specific medical device — risk management plan, hazard analysis records, risk evaluation records, risk control records, overall residual risk evaluation, risk management review, and post-production information records. It is required by ISO 14971, not ISO 13485 directly. However, under ISO 13485, the Design and Development File must contain or reference risk management records — and under the QMSR, the RMF is what FDA investigators use as their inspection roadmap.

Do I need ISO/TR 24971 as well?

ISO/TR 24971:2020 is the technical report companion to ISO 14971:2019. It provides practical guidance on implementing ISO 14971’s requirements — methods for hazard identification, risk estimation, benefit-risk analysis, and software risk management. Unlike ISO 14971, it is guidance rather than a standard with requirements. For organizations building or rebuilding their risk management program, ISO/TR 24971 is a valuable implementation companion. It is not required, but it is practically useful.

How does ISO 14971 differ from ISO 31000?

ISO 14971 is specific to medical device risk management and defines risk in terms of patient harm — the combination of probability and severity of harm to people. ISO 31000 is a broader enterprise risk management standard with a wider definition of risk that includes any effect on objectives. The two are not interchangeable in the medical device context. ISO 14971 is the expected framework for medical device risk management. ISO 31000 is not.

✅ Free Resources

📋 ISO 13485 Gap Assessment Checklist — 64 items across 7 sections including ISO 14971 risk management integration requirements and all four FDA QMSR bridge requirements. Identify your gaps before your first audit.

📋 Manufacturing Compliance Checklist — ISO 9001, 14001, 45001 & OSHA — 50 items with gap scoring across all compliance systems.

📋 Supplier Quality Checklist — ISO 9001 Clause 8.4 — all supplier controls auditors evaluate, 45 items with scoring.

📋 ISO 9001 Implementation Roadmap — The exact 5-phase process from gap assessment to Stage 2 audit clearance.

Not Sure What to Do Next?

✅ You need the official ISO 13485:2016 standard 📋 ISO 13485:2016 — ANSI Webstore — use coupon CC2026 for 5% off

✅ You need the official ISO 14971:2019 standard 📋 ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off

✅ You want to save buying both standards together 📋 ISO Standards Bundle — ANSI Webstore — Save up to 50%

✅ You want to identify your ISO 13485 and QMSR compliance gaps before spending anything 📋 Download the Free ISO 13485 Gap Assessment Checklist

✅ You need ISO 13485 training before implementation 📋 ISO 13485 Training — BSI Group

✅ You are ready to pursue ISO 13485 certification 📋 ISOQAR ISO 13485 Certification

✅ You want to understand what ISO 13485 requires 📋 What Is ISO 13485? Complete Guide

✅ You want to understand what ISO 14971 requires 📋 What Is ISO 14971? Risk Management for Medical Devices

✅ You want to understand the FDA QMSR and its impact 📋 FDA QSR vs ISO 13485 — The Complete QMSR Transition Guide

✅ You want to compare ISO 9001 and ISO 13485 📋 ISO 9001 vs ISO 13485 — Key Differences

✅ You want to understand ISO 13485 purchase options and cost 📋 Buy ISO 13485 — Complete Guide 📋 How Much Does ISO 13485 Cost?

✅ You want to browse all available medical device standards 📋 Standards Library — Medical Devices & Regulated Manufacturing 📋 Popular Standards — Most Frequently Purchased

Still Figuring Out Where to Start?

If you’re not ready to purchase or certify yet — that’s normal. ISO 13485 and ISO 14971 implementation decisions typically take three to six months from first research to commitment.

The best next step for most organizations at this stage:

📋 Download the free ISO 13485 Gap Assessment Checklist — it covers all 64 clause requirements including the ISO 14971 integration section and the four QMSR bridge requirements. It takes 30 minutes and tells you exactly where your gaps are before you spend anything.

Download Free Checklist — No Cost

ISO 13485 and ISO 14971 Are Not Optional to Each Other

ISO 13485 tells you risk management is required across your quality management system. ISO 14971 tells you how to conduct it. One without the other produces either a QMS with undefined risk methodology or a risk management program without a quality system framework to integrate it.

Under the FDA’s QMSR, effective February 2, 2026, that integration is no longer just a best practice — it is what federal regulatory inspection expects. FDA investigators start with the risk management file. They follow it into design controls, CAPA, complaint handling, and post-market surveillance. A quality management system that treats risk management as a design-phase deliverable rather than a lifecycle discipline will not hold up under that inspection approach.

The organizations that get this right are the ones that treat the Risk Management File as a living operational document — not a certification artifact. They update it because post-market data flows into it systematically. They connect CAPA to it because the system requires the connection. They identify new hazards from real-world performance data because that is what ISO 14971 Clause 11 requires and what QMSR now enforces.

That is what implementing both standards properly actually produces.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

✅ Get updates on new standards, implementation strategies, and compliance insights ✅ Be first to access new guides, tools, and checklists

Subscribe below to stay ahead.

Subscribe

* indicates required

What Is ISO 14971? Risk Management for Medical Devices Explained (2026 Guide)

ISO 14971 is not optional supplementary guidance for ISO 13485 — it is the required risk management framework woven throughout the medical device lifecycle. This guide covers what ISO 14971:2019 requires clause by clause, how its six-step process works across the device lifecycle, what changed in the 2019 edition, and why the FDA’s QMSR makes a well-maintained Risk Management File more critical than ever.

ISO 14971 is not optional supplementary guidance for ISO 13485 — it is the required risk management framework woven throughout the medical device lifecycle. Here’s what it requires, how it works, and why the FDA’s QMSR makes understanding it more important than ever.

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

From the Shop Floor

Risk management in manufacturing is not a new concept. Every process engineer who has ever run a failure modes and effects analysis on a production line understands the core logic: identify what can go wrong, estimate how likely it is and how bad it would be, put controls in place, and verify those controls work.

What ISO 14971 adds to that foundation is structure, lifecycle scope, and documentation discipline.

After 25 years in heavy industrial manufacturing — including quality systems, process control, and operational risk — the single most consistent gap I see in medical device risk management is the treatment of the Risk Management File as a design-phase deliverable rather than a living operational document. Teams build an impressive RMF during product development, get through their certification audit, and then let the file sit static while the real world generates new information about how the device actually performs.

That approach worked well enough under the old QSR. It does not work under the QMSR.

FDA investigators under CP 7382.850 are not looking at your RMF to confirm it was done — they are using it as a roadmap to evaluate whether your entire quality system is functioning as an integrated risk management framework. A risk management file that hasn’t been updated since device release is not a minor documentation gap. It is evidence that your risk management process is not integrated with complaint handling, CAPA, and post-market surveillance the way the QMSR requires.

The organizations I have seen handle this well treat the RMF update as a standing agenda item in management review — not a corrective action triggered by an audit finding. If post-market data is generating complaints, those complaints are being evaluated in the context of the risk management file every quarter. That is the operating model QMSR expects.

ISO 14971 Is the Standard Your QMS Is Already Required to Implement

If you are pursuing ISO 13485 certification, operating under the FDA’s QMSR, or manufacturing medical devices for any major regulated market, ISO 14971 is not a standard you get to choose whether to implement.

ISO 13485:2016 explicitly requires risk management per ISO 14971 throughout the medical device lifecycle — in design controls, production processes, supplier controls, complaint handling, and post-market surveillance. Under the FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, that requirement now carries federal regulatory weight. FDA investigators under Compliance Program 7382.850 are expected to use the risk management file as their inspection roadmap.

Yet despite being one of the most referenced standards in medical device regulation, ISO 14971 remains one of the least understood. Most manufacturers know it exists. Far fewer understand what it actually requires, how its six-step process works across the device lifecycle, or why the 2019 edition introduced changes that many organizations still haven’t fully implemented.

This guide covers all of it — what ISO 14971 is, what it requires clause by clause, how it integrates with ISO 13485 and the QMSR, and what your risk management program needs to look like in practice.

In This Guide

  • What ISO 14971 is and why it exists
  • Who needs ISO 14971
  • The six-step ISO 14971 risk management process
  • Key clause-by-clause breakdown
  • What changed in the 2019 edition
  • The Risk Management File — what it contains and how it’s structured
  • ISO 14971 and ISO 13485 — how they integrate
  • ISO 14971 under the FDA QMSR
  • ISO/TR 24971 — the companion guidance document
  • How to buy the official standard
  • Frequently asked questions

✅ Start Here (Top Resources)

📋 Purchase the official ISO 14971:2019 standard → ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off through December 31, 2026

📋 Purchase the official ISO 13485:2016 standard — required companion → ISO 13485:2016 — ANSI Webstore — use coupon CC2026 for 5% off

📋 Save up to 50% buying both standards as a bundle → ISO Standards Packages — ANSI Webstore

📋 Get ISO 13485 training that covers ISO 14971 integration → BSI Group ISO 13485 Training

📋 Get ISO 13485 certified with an accredited certification body → ISOQAR ISO 13485 Certification

What Is ISO 14971?

ISO 14971 is the international standard for the application of risk management to medical devices. The current version — ISO 14971:2019 — is the third edition, published in December 2019. It specifies the terminology, principles, and a structured process for identifying hazards associated with medical devices, estimating and evaluating the associated risks, controlling those risks, and monitoring the effectiveness of controls throughout the entire device lifecycle.

The standard applies to:

  • Physical medical devices of all classifications
  • Software as a Medical Device (SaMD)
  • In vitro diagnostic (IVD) medical devices
  • Combination products where the device constituent part requires risk management

Before ISO 14971, there was no universally accepted methodology for risk management in the medical device industry. Different manufacturers used different approaches, different terminology, and different standards for what constituted acceptable risk. ISO 14971 introduced a standardized process that could be consistently applied across the industry globally — giving regulators, certification bodies, and trading partners a shared framework for evaluating whether a manufacturer’s risk management is adequate.

Risk, as defined by ISO 14971, is the combination of two components:

  1. The probability that harm will occur
  2. The severity of that harm

This definition is important because it shapes the entire risk management process. A high-severity potential harm that is extremely unlikely to occur produces a different risk level than a moderate-severity harm that occurs frequently. ISO 14971 requires manufacturers to evaluate both dimensions systematically — not rely on intuition or experience alone.

Who Needs ISO 14971?

ISO 14971 is effectively required for any organization involved in the medical device supply chain. Specifically:

Organizations that must implement ISO 14971:

  • Medical device manufacturers — it is explicitly required by ISO 13485 and referenced throughout FDA QMSR, EU MDR, Health Canada, TGA (Australia), and most other major regulatory frameworks
  • Design-responsible organizations developing medical devices or device software
  • Contract manufacturers producing devices under a design owner’s technical file

Organizations that should implement ISO 14971:

  • Component suppliers whose products are incorporated into medical devices — risk management requirements are increasingly flowed down through quality agreements
  • Software developers producing SaMD or software incorporated into medical devices
  • Sterilization service providers — sterilization process risk must be managed within the device’s overall risk management framework

A critical distinction: ISO 14971 is not legally mandated in the same way a regulation is — regulators like the FDA do not list it as a statutory requirement. However, regulators worldwide recognize ISO 14971 as the state of the art for medical device risk management. Non-conformance with ISO 14971 — or the absence of a risk management program built on its framework — creates significant regulatory exposure. For practical purposes, ISO 14971 is mandatory for any organization intending to demonstrate that their device is safe and effective.

The ISO 14971 Risk Management Process — Six Steps

Infographic illustrating the six-step ISO 14971 medical device risk management process: Risk Analysis, Risk Evaluation, Risk Control, Overall Residual Risk, Risk Management Review, and Post-Production Information.
The six-step ISO 14971 risk management process creates a structured lifecycle approach for identifying hazards, controlling risks, evaluating residual risk, and continuously improving medical device safety.

ISO 14971 defines a six-step risk management process that applies across the entire device lifecycle — from initial concept through design, production, and post-market activities.

Step 1 — Risk Analysis

Risk analysis is the systematic use of available information to identify hazards and estimate the risks associated with a medical device. It consists of two activities:

Hazard identification: Identifying all reasonably foreseeable hazards associated with the device under both normal use conditions and fault conditions. The 2019 edition specifically requires both normal and fault conditions to be considered — a change from the 2007 edition which emphasized fault conditions primarily.

Sources of hazards include:

  • Device energy sources (electrical, thermal, mechanical, radiation)
  • Device materials and their biological interactions
  • Use environment and user characteristics
  • Reasonably foreseeable misuse
  • Software failures and cybersecurity vulnerabilities
  • Interactions with other devices

Risk estimation: For each hazardous situation identified, estimating the risk by determining the probability of occurrence of harm and the severity of that harm. ISO 14971 does not specify acceptable risk levels — manufacturers must establish their own objective criteria based on regulatory requirements, industry standards, and clinical context.

Step 2 — Risk Evaluation

Risk evaluation is the process of comparing estimated risks against the manufacturer’s defined risk acceptability criteria to determine whether risk reduction is required. If the estimated risk exceeds acceptable levels, the process moves to risk control. If the risk is within acceptable limits, it is documented as acceptable residual risk and monitored.

Step 3 — Risk Control

Risk control is the process of implementing and verifying measures to reduce risks that exceed acceptable levels. ISO 14971 requires risk control measures to be implemented in a defined priority order:

  1. Inherent safety by design — eliminate or reduce hazards through design decisions (preferred)
  2. Protective measures — guards, alarms, interlocks in the device or manufacturing process
  3. Information for safety — warnings, instructions for use, training requirements (last resort)

After implementing risk control measures, the residual risk — the risk remaining after controls — must be estimated and evaluated again. The process is iterative: if residual risk is still unacceptable, additional risk control measures must be implemented.

Risk control measures must also be evaluated for introduced risks — a control measure that eliminates one hazard may introduce a new one.

Step 4 — Evaluation of Overall Residual Risk

After all individual risks have been addressed, the overall residual risk of the device must be evaluated — not just each individual risk in isolation. If the overall residual risk is not acceptable using the manufacturer’s risk acceptability criteria, a benefit-risk analysis must be performed.

Benefit-risk analysis (introduced as a formal requirement in the 2019 edition) evaluates whether the clinical benefits of the device outweigh the overall residual risk in the context of the device’s intended use. If the benefits outweigh the risks, and appropriate information is provided to users, the device may be released. If the benefits do not outweigh the risks, the device cannot be released — additional risk control measures are required.

Step 5 — Risk Management Review

Before a device is released for distribution, a formal risk management review must be completed. The 2019 edition changed the title of this clause from “Risk Management Report” to “Risk Management Review” — a deliberate signal that this is an active review activity, not simply a summary document.

The review must confirm:

  • The risk management plan has been fully implemented
  • The overall residual risk is acceptable
  • Appropriate methods are in place to collect and review production and post-production information

Reviewers must be identified in the risk management plan in advance — they cannot be appointed after the fact.

Step 6 — Production and Post-Production Information

Risk management does not end when the device is released. ISO 14971 requires a systematic process for collecting and reviewing information from production and post-market activities throughout the device’s commercial life. This includes:

  • Complaint data and adverse event reports
  • Post-market surveillance information
  • Production nonconformances and CAPA trends
  • New scientific and technical information relevant to device safety

When this information indicates that the risk management process needs to be updated — that a new hazard has been identified, or that an existing risk estimate was incorrect — the risk management file must be revised and risk control measures re-evaluated.

ISO 14971 Clause-by-Clause Breakdown

ClauseTitleKey Content
1ScopeApplicability to all medical devices, SaMD, IVDs, combination products
2Normative referencesISO 9000:2015 for defined terms
3Terms and definitions31 defined terms including risk, hazard, harm, hazardous situation, benefit
4General requirementsRisk management system requirements, management responsibilities, competence requirements
5Risk management planningRisk management plan requirements — device scope, lifecycle phases, risk acceptability criteria
6Risk analysisIntended use, hazard identification, risk estimation
7Risk evaluationComparison to acceptability criteria, benefit-risk analysis (Clause 7.4)
8Risk controlControl option analysis, measure implementation, residual risk evaluation, introduced risks
9Evaluation of overall residual riskOverall residual risk acceptability, benefit-risk if needed
10Risk management reviewPre-release review requirements, reviewer identification
11Production and post-production activitiesInformation collection, new hazard identification, risk file updates

What Changed in ISO 14971:2019

The 2019 edition is the third edition of ISO 14971, replacing the 2007 version. Several changes have practical implementation implications:

Benefit-risk analysis is now a formal requirement. The 2019 edition formally introduced benefit-risk analysis as a defined process step (Clause 7.4) when overall residual risk is not acceptable under the manufacturer’s criteria alone. The 2007 edition referenced this concept but did not treat it as a structured requirement. The FDA’s influence here is direct — the FDA revised its language to place “benefit” before “risk” for novel device submissions, and the ISO 14971 committee adopted this framing in the 2019 revision.

Both normal and fault conditions must be analyzed. Clause 5.4 of the 2019 edition explicitly requires identification of anticipated hazards under both normal use and fault conditions. The 2007 edition emphasized fault conditions — the 2019 edition closes that gap. This has direct implications for FMEA and hazard analysis documentation.

Post-production requirements are more prescriptive. The requirements for production and post-production information collection (Clause 11) are more detailed in the 2019 edition, with stronger emphasis on systematic feedback of real-world performance data into the risk management file.

Risk Management Review replaces Risk Management Report. The title change in Clause 9 (from “report” to “review”) reflects a substantive intent: the activity must be an active review with identified reviewers, not a passive summary document compiled at device release.

EN ISO 14971:2019 + A11:2021 for EU MDR. The European version of the standard includes Amendment A11:2021, which maps ISO 14971 requirements to the General Safety and Performance Requirements (GSPR) of the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). Organizations selling into the EU need the A11 annex — organizations selling only in the U.S. do not, but the normative requirements are identical in both versions.

The Risk Management File

The Risk Management File (RMF) is the central documentation output of the ISO 14971 process. It is the organized collection of records that demonstrates a manufacturer has systematically identified hazards, evaluated risks, implemented controls, and monitored the effectiveness of those controls throughout the device lifecycle.

The RMF is not a single document. It is a defined collection of records that includes:

  • Risk Management Plan (RMP): Defines the scope of risk management activities, the lifecycle phases covered, the risk acceptability criteria, the risk estimation methodology, and the verification activities planned
  • Risk Analysis records: Hazard identification outputs, risk estimation records, FMEA or other analysis tool outputs
  • Risk Evaluation records: Comparison of estimated risks against acceptability criteria
  • Risk Control records: Selected control measures, implementation records, verification that controls achieved their intended risk reduction, evaluation of introduced risks
  • Overall Residual Risk evaluation: Documentation of the overall residual risk assessment and benefit-risk analysis if required
  • Risk Management Review: Pre-release review record with identified reviewers
  • Post-Production information records: Systematic records of production and post-market information reviewed against the risk management file

A common audit finding is a Risk Management File that functions as a static document compiled at device release — rather than a living record updated throughout the device’s commercial life as post-production information is gathered. Under the QMSR, FDA investigators start inspections with the risk management file. A static RMF that hasn’t been updated since initial device release is a significant inspection vulnerability.

Feature image promoting an ISO 13485 Gap Assessment Checklist for medical device manufacturers, contract manufacturers, and component suppliers preparing for certification and FDA QMSR compliance.
ISO 13485 Gap Assessment Checklist designed to help medical device manufacturers identify compliance gaps, prioritize actions, and prepare for certification and FDA QMSR requirements.

📋 How does your risk management program measure up? Section 6 of the free ISO 13485 Gap Assessment Checklist covers ISO 14971 integration specifically — risk management plan requirements, RMF structure, post-production feedback, and the QMSR inspection implications. Download Free Checklist

ISO 14971 and ISO 13485 — How They Integrate

ISO 14971 and ISO 13485 are companion standards — not alternatives. ISO 13485 is the quality management system framework. ISO 14971 is the risk management framework that ISO 13485 requires to be implemented throughout that QMS.

ISO 13485 references ISO 14971 in multiple clauses:

  • Clause 7.1 — Planning of product realization: Risk management activities must be planned as part of product realization
  • Clause 7.3 — Design and development: Risk management must be integrated throughout design and development activities
  • Clause 7.4 — Purchasing: Supplier controls must reflect risk — suppliers of higher-risk components require more rigorous qualification
  • Clause 8.2.1 — Feedback: Post-market feedback must be evaluated in the context of risk management
  • Clause 8.5 — Improvement: CAPA and continual improvement activities must consider risk management outputs

ISO 14971 is not optional supplementary guidance for ISO 13485. Organizations implementing ISO 13485 must purchase and implement ISO 14971. It is an external document that must be controlled under ISO 13485 Clause 4.2.4 — registered, version-controlled, and accessible to relevant personnel.

For a complete comparison of how ISO 13485 and risk management requirements interact, see ISO 9001 vs ISO 13485 — Key Differences.

📋 Buy ISO 13485:2016 — ANSI Webstore — use coupon CC2026 for 5% off

Infographic mapping ISO 13485 clauses to corresponding ISO 14971 risk management requirements, showing how quality management processes trigger risk management activities across the medical device lifecycle.
ISO 13485 establishes quality system requirements, while ISO 14971 provides the risk management framework that connects planning, design, purchasing, feedback, and improvement activities throughout the medical device lifecycle.

ISO 14971 Under the FDA QMSR

The FDA’s Quality Management System Regulation (QMSR), effective February 2, 2026, incorporated ISO 13485:2016 by reference into 21 CFR Part 820 — and with it, ISO 13485’s explicit requirement for risk management per ISO 14971.

Under QMSR, several specific changes elevate the practical importance of ISO 14971:

Risk management now extends across the entire QMS. Under the old QSR, risk management was concentrated primarily in design controls. Under QMSR, risk-based thinking is required throughout the entire quality system — supplier controls, production processes, CAPA, complaint handling, and post-market surveillance. ISO 14971 is the expected framework for implementing this expanded risk management scope.

FDA investigators start inspections with the risk management file. Under Compliance Program 7382.850 — the new inspection program that replaced QSIT on February 2, 2026 — FDA investigators are expected to begin inspections by reviewing the risk management file and following risk documentation into other quality system areas. A well-maintained, current risk management file is inspection preparation. An incomplete or static risk management file is an inspection liability.

Post-market surveillance feeds the risk management file. The QMSR’s requirements for production and post-production information — complaint handling, MDR, field corrections — are expected to feed systematically into the risk management file. Organizations that maintain complaint handling and risk management as separate, unconnected systems have a QMSR gap.

For the complete QMSR transition guide, see FDA QSR vs ISO 13485: The Complete QMSR Transition Guide.

ISO/TR 24971 — The Companion Guidance Document

ISO/TR 24971:2020 is the technical report published as a companion to ISO 14971:2019. Unlike ISO 14971, which is a normative standard (its requirements are mandatory for certification purposes), ISO/TR 24971 is guidance — it does not add requirements but provides practical methodology for implementing ISO 14971’s requirements.

ISO/TR 24971:2020 covers:

  • Guidance on risk management planning
  • Practical methods for hazard identification and risk estimation
  • Guidance on benefit-risk analysis
  • Application of risk management to software
  • Application of risk management to usability and human factors
  • Guidance on production and post-production information processes

For organizations building or rebuilding their risk management program, ISO/TR 24971 is the practical implementation companion to ISO 14971’s requirements. Many experienced quality and regulatory professionals recommend reading both together.

📋 ISO/TR 24971:2020 — ANSI Webstore — use coupon CC2026 for 5% off

How to Buy ISO 14971

ISO 14971 is a copyrighted document and must be purchased from an authorized source. It cannot be legally downloaded for free.

The ANSI Webstore is the authorized U.S. distributor for ISO standards. ISO 14971:2019 is available in PDF format with immediate download after purchase.

📋 ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off through December 31, 2026

Bundle with ISO 13485 — Save Up to 50%

Organizations implementing ISO 13485 need both standards. Purchasing as a bundle through the ANSI Webstore saves significantly compared to individual purchases.

📋 ISO Standards Bundles — Save up to 50%

For the complete guide to purchasing ISO 13485, see Buy ISO 13485 — Complete Purchasing Guide.

Frequently Asked Questions

What is ISO 14971 used for?

ISO 14971 is the international standard for applying risk management to medical devices. It provides the structured process — hazard identification, risk estimation, risk evaluation, risk control, overall residual risk evaluation, and post-production monitoring — that manufacturers must use to demonstrate that their devices are safe for their intended use.

Is ISO 14971 required for ISO 13485 certification?

Yes. ISO 13485 explicitly requires risk management per ISO 14971 throughout the medical device quality management system. Organizations cannot achieve ISO 13485 certification without demonstrating that their risk management program is built on the ISO 14971 framework. ISO 14971 must be controlled as an external document within the ISO 13485 QMS.

Is ISO 14971 required by the FDA?

ISO 14971 is not listed as a statutory FDA requirement. However, the FDA recognizes ISO 14971 as the state of the art for medical device risk management. Under the QMSR, effective February 2, 2026, ISO 13485 is incorporated by reference into 21 CFR Part 820 — and ISO 13485 explicitly requires ISO 14971. FDA investigators under CP 7382.850 use the risk management file as their inspection starting point. For practical purposes, ISO 14971 is effectively mandatory for any FDA-regulated medical device manufacturer.

What is the difference between ISO 14971:2007 and ISO 14971:2019?

The 2019 edition introduced several substantive changes: benefit-risk analysis is now a formal requirement when overall residual risk is not acceptable; both normal use and fault conditions must be analyzed during hazard identification; post-production requirements are more prescriptive; and the Risk Management Report was renamed Risk Management Review to signal an active review activity rather than a passive document.

What is the Risk Management File?

The Risk Management File (RMF) is the organized collection of records that demonstrates a manufacturer has systematically implemented the ISO 14971 risk management process. It includes the Risk Management Plan, hazard analysis records, risk evaluation records, risk control records, overall residual risk evaluation, risk management review, and post-production information records. The RMF is a living document — it must be updated throughout the device’s commercial life as post-production information is gathered.

What is ISO/TR 24971?

ISO/TR 24971:2020 is the technical report companion to ISO 14971:2019. It provides practical guidance on implementing ISO 14971’s requirements — methods for hazard identification, risk estimation, benefit-risk analysis, software risk management, and post-production information processes. It does not add normative requirements but is an essential practical companion for organizations building or rebuilding their risk management programs.

What is the difference between ISO 14971 and ISO 31000?

ISO 14971 is specific to medical device risk management and defines risk purely in terms of harm to people — the combination of probability of harm and severity of that harm. ISO 31000 is a broader enterprise risk management standard with a wider definition of risk that includes any effect on objectives, including positive risks (opportunities). The two standards serve different purposes and are not interchangeable in the medical device context.

Does ISO 14971 apply to software as a medical device?

Yes. ISO 14971:2019 explicitly applies to Software as a Medical Device (SaMD). ISO/TR 24971 provides specific guidance on applying ISO 14971 to software. The companion standard IEC 62304 — Medical Device Software Lifecycle Processes — also references ISO 14971 risk management requirements throughout its software development lifecycle requirements.

📥 Free Resources

Not Sure What to Do Next?

✅ You need the official ISO 14971:2019 standard 📋 ISO 14971:2019 — ANSI Webstore — use coupon CC2026 for 5% off through December 31, 2026

✅ You also need ISO 13485:2016 — the required companion QMS standard 📋 ISO 13485:2016 — ANSI Webstore — use coupon CC2026 for 5% off

✅ You need the ISO/TR 24971 implementation guidance companion 📋 ISO/TR 24971:2020 — ANSI Webstore — use coupon CC2026 for 5% off

✅ You want to save buying multiple standards together 📋 ISO Standards Bundles — Save up to 50% — ANSI Webstore

✅ You need ISO 13485 training that covers ISO 14971 integration 📋 BSI Group ISO 13485 Training

✅ You are ready to pursue ISO 13485 certification 📋 ISOQAR ISO 13485 Certification

✅ You want to understand what ISO 13485 requires 📋 What Is ISO 13485? — Complete Guide

✅ You want to understand the FDA QMSR and how ISO 14971 fits 📋 FDA QSR vs ISO 13485 — The Complete QMSR Transition Guide

✅ You want to compare ISO 9001 and ISO 13485 📋 ISO 9001 vs ISO 13485 — Key Differences

✅ You want to understand ISO 13485 purchase options and cost 📋 Buy ISO 13485 — Complete Purchasing Guide 📋 How Much Does ISO 13485 Cost?

Risk Management Is Not a Deliverable. It’s an Operating Model.

ISO 14971 is not a checkbox on a certification audit list. It is the framework that determines whether the medical devices your organization produces — or supplies components for — are demonstrably safe for their intended use.

Under the FDA’s QMSR, effective February 2, 2026, that framework now carries federal regulatory weight. Risk management under QMSR extends across the entire quality system, and FDA investigators under CP 7382.850 are using the risk management file as their inspection roadmap.

The organizations that navigate this environment successfully are the ones that treat risk management as an operating discipline — not a documentation exercise. The Risk Management File is updated because post-market data is being systematically reviewed, not because an audit is scheduled. CAPA is connected to the risk management file because the quality system is integrated, not because an investigator asked to see the connection.

That is what ISO 14971, properly implemented, actually produces.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

✅ Get updates on new standards, implementation strategies, and compliance insights ✅ Be first to access new guides, tools, and checklists

Subscribe below to stay ahead.

Subscribe

* indicates required